{
  "title": "M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the following topics:\nTopic\nTopic Name\n1\nSelecting Diagnostic Codes (DCs)\n2\nDetermining a Disability Evaluation Based on Rating Schedule Criteria\n3\nExtra-schedular Evaluations\n4\nPermanent and Total (P&T) Evaluations\n5\nPrinciples of Disability Evaluation for Specific Conditions\n1\n.\nSelecting DCs\nIntroduction\nThis topic includes information to supplement the regulatory provisions for selection of  DCs to evaluate disabilities in the\nDepartment of Veterans Affairs (VA) Schedule for Rating Disabilities\n, including\nchoosing from multiple possible DCs\nuse of hyphenated DCs\nusing analogous codes\nwhen to avoid rating by analogy\nimpact of a change in DC\n, and\nhandling a change in diagnosis\n.\nChange Date\nMay 29, 2025\nV.ii.3.D.1.a\n.\nChoosing From Multiple Possible DCs\nDiagnostic Codes (DCs) must be carefully selected and reasons for selection given if two or more are applicable.  When multiple DCs apply to a given disability, consider\nwhether separate evaluations are warranted, and/or\nwhich DC will result in the most advantageous outcome for the claimant.\nReferences\n:  For more information on\ndetermining whether separate evaluations are warranted, see\nM21-1, Part V, Subpart ii, 3.D.2.b\n, and\n38 CFR 4.14\nproviding the reason for selection of a DC in the rating decision, see\nM21-1, Part V, Subpart iv, 1.A.6.B\n, and\nSuttman v. Brown\n, 5 Vet.App. 127 (1993), and\nprocedures for entering DCs in the Veterans Benefits Management System-Rating (VBMS-R), see\nM21-1, Part V, Subpart iv, 1.C.2\n.\nV.ii.3.D.1.b\n.\nUse of Hyphenated DCs\nHyphenated DCs may be utilized for diseases or injuries.  The use of a hyphenated DC is not intended to substitute for appropriate assignment of separate evaluations for different disabilities arising from a single injury.\nReferences\n:  For more information on the\nuse of hyphenated DCs, see\n38 CFR 4.27\nM21-1, Part V, Subpart iv, 1.C.2.c and d\n, and\nTropf v. Nicholson\n, 20 Vet.App. 317 (2006)\nuse of hyphenated DCs for qualifying disabilities associated with service in Southwest Asia, see\nM21-1, Part VIII, Subpart ii, 1.C.2.b\n, and\nassignment of separate evaluations for individual manifestations of a disease or injury, see\nM21-1, Part V, Subpart ii, 3.D.2.b\n, and\nEsteban v. Brown\n, 6 Vet.App. 259 (1994).\nV.ii.3.D.1.c\n.\nUsing Analogous Codes\nUse analogous codes to evaluate disabilities not listed in\n38 CFR Part 4\n,\nthe\nDepartment of Veterans Affairs\n(\nVA) Schedule for Rating Disabilities\n, based on\nfunction(s) affected\nanatomical location, and\nsymptomatology.\nThese factors\nmust\nbe discussed in the rating decision\nNarrative\nwhen a disability is evaluated under an analogous DC.\nWhen a claimant (or representative) requests a disability be evaluated under a specific DC and the claims processor chooses to evaluate the disability under an alternative DC, the rating decision\nNarrative\nmust\nexplain (in sufficient detail) why the particular analogous DC was selected and why the requested DC was not appropriate to evaluate the Veteran’s disability.\nIn cases where there is no other reasonable alternative DC for analogous purposes, other than the selected analogous DC, the claims processor should indicate this in the\nNarrative\n.\nReferences\n:  For more information on analogous ratings, see\n38 CFR 4.20\nM21-1, Part V, Subpart iv, 1.C.2\nLendenmann v. Principi\n, 3 Vet.App. 345 (1992), and\nWebb v. McDonough\n, 71 F.4th 1377 (Fed.Cir. 2023).\nV.ii.3.D.1.d\n.\nWhen to Avoid Rating by Analogy\nWhen a condition is specifically listed in the rating schedule, it may not be rated by analogy.\nWhen there is a diagnosis of two separate conditions, apply the DC(s) that specifically pertains to the listed conditions and determine the appropriate disability evaluations.\nReference\n:  For more information on analogous ratings, see\nCopeland v. McDonald\n, 27 Vet.App. 333 (2015)\n.\nV.ii.3.D.1.e\n.\nImpact of a Change in DC\nService connection (SC) of a disability is not severed when the site of a disability or the DC associated with it is corrected to more accurately determine the benefit to which a Veteran may be entitled.  The diagnosis or site of the existing service-connected (SC) condition may be corrected to accurately reflect the actual anatomical location of the injury or disease resulting in the Veteran’s disability, provided the redesignation does not result in severance of SC for the disability in question.\nHowever, a change in DC cannot serve to reduce a protected disability evaluation where the symptoms upon which the evaluation was based are no longer present.\nA change of diagnosis shown on examination or in other medical evidence must be reconciled to determine whether the underlying disability is the same condition or a progression of the condition that was previously diagnosed under a different diagnosis or whether a new disability, unrelated to the prior diagnosis, is being addressed.\nExample 1\n:  A Veteran is SC for gunshot wound (GSW) of the right thigh muscle group (MG) XIII under\n38 CFR 4.73, DC 5313\nwith a 10-percent evaluation assigned based on moderate impairment.  Subsequent evidence showed that the GSW actually impacted only MG XV, which is evaluated under\n38 CFR 4.73, DC 5315\nand that there was never an injury to or impairment of MG XIII.  In this situation, since the correction of DC serves only to correct the site of the impairment and does not serve to effectively sever SC for an otherwise properly established disability, the change in DC is warranted.\nExample 2\n:  A Veteran is SC under\n38 CFR 4.71a, DC 5257\nfor mild instability of the left knee shown on examination.  The evaluation has been in place for over 20 years and is protected under\n38 CFR 3.957\n.  A claim for increase is received.  The resultant examination shows no instability of the left knee but does show arthritis and pain related to the SC injury.  In this situation, the 10-percent evaluation assigned under\n38 CFR 4.71a, DC 5257\nmay not be reduced or eliminated.  However, since there are separately compensable disabilities shown in the record, a separate evaluation for arthritis may be assigned under\n38 CFR 4.71a, DC 5010\n.\nReferences\n:  For more information on\nthe applicability of protection for\nan SC evaluation under\n38 CFR 3.951\nwhen\na DC is changed, see\nM21-1, Part X, Subpart ii, 1.B.1.k\n, and\nthe condition has been evaluated with a single disability evaluation which is now being replaced by separate evaluation, see\nM21-1, Part X, Subpart ii, 1.B.1.l\n, and\nSC under\n38 CFR 3.957\nwhen a DC is being changed or the site of a disability is being corrected, see\nM21-1, Part X, Subpart ii, 1.B.2.d\nhandling examination reports reflecting a change or conflict in diagnoses, see\n38 CFR 4.2\n, and\nM21-1, Part IV, Subpart i, 3.C\ndetermining whether a change in DC effectively results in severance of SC, see\nVAOPGCPREC 50-1991\nRead v. Shinseki\n, 651 F.3d 1296 (2011), and\nMurray v. Shinseki\n, 24 Vet.App. 420 (2011).\nV.ii.3.D.1.f\n.\nHandling a Change in Diagnosis\n38 CFR 4.13\ndirects that evidence suggesting a change in the diagnosis of an SC disability must be reviewed with a goal of reconciling the discrepancy and maintaining SC for the disability, where possible.  Reconciliation is necessary to ensure\naccuracy of the diagnosis, and\nthat the proper disability has been examined and is being evaluated.\nRefer to the table below for actions to take when a change in diagnosis of an SC disability is shown.\nIf the ...\nThen ...\nchange in diagnosis is shown on a VA examination and the examiner does not reconcile the change in diagnosis\nreturn the examination report for clarification as directed at\nM21-1, Part IV, Subpart i, 3.C\n.\nchange in diagnosis is shown in outpatient treatment records or other medical evidence\nrequest a medical opinion and examination (if warranted) to reconcile the change in diagnosis.\nmedical evidence definitively shows that the diagnosis has changed and that the prior diagnosis was clearly erroneous\nfollow the procedures for severance of SC as directed at\nM21-1, Part X, Subpart ii, 5.B\n.\nReference\n:  For more information on special procedures for handling severance of SC for disabilities granted under\n38 CFR 3.317\n, see\nM21-1, Part VIII, Subpart ii, 1.C.2.e and f\n.\nmedical evidence shows that the change in diagnosis represents a progression of the SC disability\nupdate the diagnosis to reflect the current diagnosis as well as the historical diagnosis.\nExample\n:  right knee arthritis (previously diagnosed as strain)\nmedical evidence shows that the change in diagnosis represents a separate disability and reflects that the SC disability still exists\nobtain adequate evidence to evaluate the SC disability and separate the symptoms of the SC disability from the non-service-connected (NSC) disability.\nReference\n:  For more information on assigning a disability evaluation when the symptoms of an SC and NSC disability cannot be separated, see\nM21-1, Part V, Subpart ii, 3.D.2.c\n.\n2\n.\nDetermining a Disability Evaluation Based on Rating Schedule Criteria\nIntroduction\nThis topic includes general principles for determining a disability evaluation based on rating schedule criteria, including\nrelationships within evaluation criteria\nseparating individual findings and pyramiding\nevaluating symptoms of SC and NSC disabilities that cannot be separated\nconsidering rating criteria that utilize “such as”\nchoosing between two levels of evaluation\nassignment of zero-percent evaluations\nassigning a 10-percent evaluation for multiple noncompensable SC disabilities\ndetermining the retroactive applicability of a new statute or regulation\neffect of rating schedule readjustment\nassigning staged ratings\n, and\nuse of the Evaluation Builder\n.\nChange Date\nSeptember 15, 2021\nV.ii.3.D.2.a\n.\nRelationships Within Evaluation Criteria\nIn determining which fact findings are required to make a legal conclusion,\ngenerally\nif regulatory criteria are\nconjunctive\n(separated by “and”), all of the conjoined criteria must be met for the legal standard of entitlement to be met, or\ndisjunctive\n(separated by “or”), any one of the alternative criteria will support entitlement to the benefit.\nThe manner in which evaluation criteria relate to the lower and higher evaluation criteria within the same DC is also relevant when assigning evaluations.\nCumulative\nrating criteria are characterized by the lower evaluations building upon each other.\nSuccessive\nrating criteria are a type of cumulative criteria characterized by higher evaluations for increased duration of symptoms.\nVariable\nrating criteria are characterized by a lack of relationship between one set of evaluation criteria to the higher or lower evaluation criteria for the same DC.  In variable rating criteria, symptoms could potentially meet the criteria required for a higher evaluation without satisfying the criteria for a lesser evaluation.\nImportant\n:\nConjunctive language is\nalways\nsubject to the reasonable doubt principles in\n38 CFR 3.102\nwhen the evidence is in relative equipoise or when there is a question regarding degree of disability.\n38 CFR 4.21\ndoes not apply to conjunctive rating criteria.\n38 CFR 4.7\nis an important consideration when evaluating a disability using variable rating criteria.\nReferences\n:  For more information on\nthe application of\nthe rating schedule, see\n38 CFR 4.21\n, and\n38 CFR 4.7\nin variable rating criteria, see\nTatum v. Shinseki\n, 23 Vet.App. 152 (2009), and\nutilizing successive rating criteria, see\nCamacho v. Nicholson\n, 21 Vet.App. 360 (2007).\nV.ii.3.D.2.b\n.\nSeparating Individual Findings and Pyramiding\nDo\nnot\nseparate individual findings when these findings, in their entirety, constitute one disability.  This is\nfundamental to the proper evaluation of a disability, and\nconsistent with the prohibition against pyramiding under\n38 CFR 4.14\n.\nNote\n:\nPyramiding\nis rating the same physical manifestations of a disability under two separate DCs.  Separate evaluations are warranted where none of the symptomatology for any one condition duplicates or overlaps another (\nEsteban v. Brown\n, 6 Vet.App. 259, 261-62 (1994)).\nExample 1\n:  A disability of a tibia with malunion, limitation of dorsiflexion, eversion, inversion, and traumatic arthritis of the ankle would be evaluated under one DC,\n38 CFR 4.71a, DC 5262\n, in accordance with the effect upon ankle function, with no separate evaluation for the limitation of motion or traumatic arthritis.\nExample 2\n:  A shoulder disability manifest as limitation of motion of the arm is entitled to a single rating under\n38 CFR 4.71a, DC 5201\n, regardless of how many planes of motion are affected.\nExample 3\n:  Instability of the knee (\n38 CFR 4.71a, DC 5257\n) may be evaluated separately from limited motion of the knee due to arthritis (\n38 CFR 4.71a, DC 5003\n).\nRefe\nr\nence\n:  For more information on separating individual findings for knee disabilities, see\nM21-1, Part V, Subpart iii, 1.B.4\nVAOPGCPREC 23-1997\n, and\nVAOPGCPREC 9-1998\n.\nV.ii.3.D.2.c\n.\nEvaluating Symptoms of SC and NSC Disabilities That Cannot Be Separated\nIf it is not possible to separate the effects of an NSC condition from those of an SC condition, reasonable doubt, under\n38 CFR 3.102\n, should be resolved in the Veteran’s favor with regard to whether certain signs and symptoms can be attributed to the SC condition.\nWhen evaluating an SC disability for rating purposes, if it is not possible to differentiate the Veteran’s symptoms from an SC and NSC disability, all symptoms should be deemed related to the SC disability and rated accordingly.\nImportant\n:\nAlthough the combined symptoms of the SC and NSC disabilities are used to support the assigned disability evaluation, the NSC disability is not considered SC.\nThe decision that the symptoms of the SC and NSC disabilities cannot be separated is a medical determination.  When the record is not clear as to whether the symptoms can be separated, obtain a medical opinion for clarification.\nReferences\n:  For more information on\nevaluating symptoms of SC and NSC disabilities that\ncannot be separated, see\nMittleider v. West\n, 11 Vet.App. 181 (1998), and\ncan be separated, see\nLangdon v. Wilkie\n, 32 Vet.App. 291 (2020)\nevidence requiring further development, see\nM21-1, Part V, Subpart ii, 3.B\n, and\nreturning examination reports for clarification, see\nM21-1, Part IV, Subpart i, 3.C\n.\nV.ii.3.D.2.d\n.\nConsidering Rating Criteria That Utilize “Such As”\nThe use of the phrase “such symptoms as,” or a similar phrase, followed by a list of examples, provides guidance as to the variety of symptoms contemplated for each rating, and permits consideration of other symptoms, particular to each Veteran and condition.\nReference\n:  For more information on the use of the term “such symptoms as” in the schedule of ratings for mental disorders, see\nMauerhan v. Principi\n, 16 Vet.App. 436 (2002).\nV.ii.3.D.2.e\n.\nChoosing Between Two Levels of Evaluation\n38 CFR 4.7\nprovides that where there is a question upon review of the evidence as to which of two evaluations shall be assigned, the higher evaluation will be assigned if the disability picture more nearly approximates the criteria required for that rating.  Otherwise, the lower rating will be assigned.\nImportant\n:\n38 CFR 4.7\ndoes not preclude application of the reasonable doubt doctrine.  When the decision maker concludes that the facts equally (or approximately equally) support two levels of evaluation such that each is as likely as not warranted, the higher evaluation will be awarded.\nReference\n:  For more information on the application of variable, cumulative, and successive rating criteria and when\n38 CFR 4.7\napplies, see\nM21-1, Part V, Subpart ii, 3.D.2.a\n.\nV.ii.3.D.2.f\n.\nAssignment of Zero-Percent Evaluations\nIn every instance where the schedule does not provide a zero-percent evaluation for a DC, a zero-percent evaluation shall be assigned when the requirements for a compensable evaluation are not met.\nException\n:  Never assign a zero-percent evaluation to a condition for which the rating schedule directs a\nprescribed, schedular minimum\nrating.  Prescribed, schedular minimum ratings, in this context as well as that of\nM21-1, Part IV, Subpart i, 2.F.1.a\nand\n38 CFR 3.327(b)\n, refer exclusively to instances in which the rating schedule requires assignment of a certain compensable evaluation once the underlying disability manifests or exists in the manner described.  Examples include\n38 CFR 4.124a, DC 8009\n, which requires that residuals of brain vessel hemorrhage be assigned a minimum rating of 10 percent\n38 CFR 4.104, DC 7019\n, which requires that residuals of cardiac transplantation be assigned a minimum rating of 30 percent, and\n38 CFR 4.116, DC 7617\n, which requires that postoperative removal of the uterus and both ovaries be assigned a minimum rating of 50 percent.\nReference\n:  For more information on assignment of zero-percent evaluations, see\n38 CFR 4.31\n.\nV.ii.3.D.2.g\n.\nAssigning a 10-Percent Evaluation for Multiple Noncompensable SC Disabilities\nUnder\n38 CFR 3.324\n, a single 10-percent evaluation may be assigned when all of the following criteria are met:\na Veteran is suffering from two or more separate permanent noncompensable SC disabilities\nthere are no other compensable SC disabilities,\nand\nthe SC disabilities clearly interfere with normal employability.\nNotes\n:\nPayment of compensation at the 10-percent rate cannot be made in combination with any other compensable disability evaluation.\nWhen entitlement to a 10-percent rating has been established but a subsequent rating decision establishes entitlement to a compensable evaluation for an SC disability, the grant of the compensable SC evaluation is considered the greater benefit.  It is unnecessary to close out the past grant of entitlement under\n38 CFR 3.324\n, as VBMS recognizes payment for the compensable disability as the greater benefit.\nReference\n:  For more information on when to put into issue in a rating decision and decide entitlement to a 10-percent evaluation under\n38 CFR 3.324\n, see\nM21-1, Part V, Subpart ii, 3.A.2.b\n.\nV.ii.3.D.2.h\n.\nDetermining the Retroactive Applicability of a New Statute or Regulation\nThe provisions of a statutory or regulatory change to rating schedule criteria for evaluating disabilities are generally not retroactive unless retroactive applicability is specifically directed.  When a change that revises the rating schedule’s evaluation criteria does not specify the intent for retroactive application, assume that the new criteria do not apply prior to the effective date of the corresponding regulatory change.\nNote\n:  For claims pending on the date that a rating schedule provision is changed, it is usually appropriate to apply the\nold\nregulation in assigning disability evaluations for periods that precede the date of the change, and\nnew\nregulation in evaluating a disability for any period that begins on or after the date of the change.  After the effective date of the regulation change\na higher evaluation must be based on the new regulation, but\nthe new regulatory criteria cannot be applied to reduce an evaluation unless actual improvement has occurred as discussed in\n38 CFR 3.951(a)\nand\nM21-1, Part V, Subpart ii, 3.D.2.i\n.\nReferences\n:  For more information on\nprotection of a disability rating based on adjustment to the rating schedule, see\n38 CFR 3.951(a)\ndetermining\nthe retroactive applicability of a new statute or regulation, see\nVAOPGCPREC 7-2003\n, and\neffective dates that are based on a change of law or regulation, see\nM21-1, Part V, Subpart ii, 4.A.6\n, and\nassigning staged ratings, see\nM21-1, Part V, Subpart ii, 3.D.2.j\n.\nV.ii.3.D.2.i\n.\nEffect of Rating Schedule Readjustment\nWhen the rating schedule is readjusted, in no event shall the readjustment cause a Veteran’s disability evaluation in effect on the effective date of the readjustment to be reduced unless an improvement in the disability is shown to have occurred, even if the combined evaluation is not reduced, as indicated in\nVAOPGCPREC 19-1992\nand\n38 U.S.C. 1155\n.\nThis precedent opinion also provides that when a Veteran is receiving the minimum evaluation for a condition at the time the rating schedule is revised, and the condition subsequently undergoes an exacerbation resulting in a higher evaluation, if the condition returns to the same, symptom-free status it was in at the time of the rating schedule change, a noncompensable evaluation under the new criteria will be assigned.\nNote\n:  The February 3, 1988, revision of criteria for rating psychiatric disorders is considered a liberalizing law/VA issue as indicated in\nSabol v. Derwinski\n, U.S. Vet.App. No. 90-1123 (1992),\n38 U.S.C. 5110(g)\n,\n38 CFR 3.114\n, and\nVAOPGCPREC 19-1992\n.\nReference\n:  For more information on protection and rating schedule changes, see\nM21-1, Part X, Subpart ii, 1.B.4\n.\nV.ii.3.D.2.j\n.\nAssigning Staged Ratings\nThe term\nstaged rating\nrefers to the assignment of separate ratings for separate periods of time based on the facts found.\n38 CFR 3.105(e)\ndoes not apply to a staged rating.  Additionally,\n38 CFR 3.105(e)\nis inapplicable to disabilities rated under DCs containing a note that “any change in evaluation . . . shall be subject to the provisions of\n38 CFR 3.105(e)\n” if the reduction is part of a staged rating assigned in the grant of an original claim for such disability.\nReference\n:  For more information on assigning staged ratings, see\nFenderson v. West\n, 12 Vet.App. 119 (1999)\nHart v. Mansfield\n, 21 Vet.App. 505 (2007)\nTatum v. Shinseki\n, 24 Vet.App. 139 (2010), and\nM21-1, Part X, Subpart ii, 4.A.1.e\n.\nV.ii.3.D.2.k\n.\nUse of the Evaluation Builder\nUse of the Evaluation Builder in assigning disability evaluations in claims for compensation is mandatory.  The Evaluation Builder is programmed to represent accurate policy and procedure and should not be overridden unless specific authorization exists for doing so.\nWhen a change in policy or procedure is officially issued in either regulatory, policy, or procedural guidance and causes the Evaluation Builder to generate inaccurate results for a temporary period of time until updates can be made, decision makers are required to override the Evaluation Builder or use appropriate workarounds so that disabilities are accurately evaluated in accordance with published guidance.  In these situations, decision makers will be directed to utilize overrides or workarounds.\n3\n.\nExtra-Schedular Consideration\nIntroduction\nThis topic contains information about extra-schedular consideration, including\nextra-schedular evaluations in compensation claims\napproving extra-schedular evaluation in compensation claims\nwhen to submit compensation claims for extra-schedular consideration\nextra-schedular evaluations under 38 CFR 3.321(b)(1)\nprocedure for referring claims for extra-schedular consideration\nextra-schedular consideration in pension claims\n, and\nexhibit of\n38 CFR 3.321(b)(1) referral memorandum\n, and\n38 CFR 4.16(b) referral memorandum\n.\nChange Date\nSeptember 15, 2021\nV.ii.3.D.3.a\n.\nExtra-Schedular Evaluations in Compensation Claims\nConsider the issue of entitlement to an extra-schedular evaluation in compensation claims under\n38 CFR 3.321(b)(1)\nonly where\nthe issue is expressly raised by the Veteran, or\nthere is evidence of exceptional or unusual circumstances indicating that the rating schedule may be inadequate to compensate for the average impairment of earning capacity due to disability (for example, marked interference with employment or frequent periods of hospitalization), and\n38 CFR 4.16(b)\nwhenever\nthe issue is expressly stated\nthere is evidence that the Veteran may be unable to secure or follow a substantially gainful occupation because of an SC disability, and\ntotal disability based on individual unemployability (IU) cannot be awarded on a schedular basis.\nImportant\n:\nIf the Veteran explicitly raises the issue of extra-schedular entitlement, but the general criteria for referring the claim to Compensation Service are not met, the decision and decision notice must include an explanation of that determination.\nIn the interest of maximizing available benefit entitlement in all cases, regional offices (ROs) must explore and exhaust all possible schedular rating methods and alternatives, to include the following, before referring a claim to Compensation Service for extra-schedular consideration:\nanalogous ratings\nassignment of the higher of two potentially applicable evaluations under\n38 CFR 4.7\nresolution of reasonable doubt in favor of the claimant under\n38 CFR 4.3\npermissible means of evaluating SC disabilities under multiple separate DC criteria without pyramiding, and/or\nawards of\nIU benefits, and/or\nspecial monthly compensation (SMC).\nReferences\n:  For more information on\ntotal disability claims, see\nVAOGCPREC 6-1996\nFloyd v. Brown\n, 9 Vet.App. 88 (1996), and\nBagwell v. Brown\n, 9 Vet.App. 337 (1996)\nextra-schedular evaluations under\n38 CFR 3.321(b)(1)\n, see\nM21-1, Part V, Subpart ii, 3.D.3.d\n, and\n38 CFR 4.16(b)\n, see\nM21-1, Part V, Subpart ii, 3.D.4.b\n, and\nthe threshold analysis involved in determining propriety of extra-schedular rating referrals, see\nMorgan v. Wilkie\n, 31 Vet.App. 162 (2019).\nV.ii.3.D.3.b\n.\nApproving Extra-Schedular Evaluations in Compensation Claims\nOnly the Director of the Compensation Service (214D) may approve extra-schedular evaluations in compensation claims submitted under\n38 CFR 3.321(b)(1)\nand\n38 CFR 4.16(b)\n.\nV.ii.3.D.3.c\n.\nWhen to Submit Compensation Claims for Extra-Schedular Consideration\nSubmit compensation claims to Compensation Service for extra-schedular consideration under\n38 CFR 3.321(b)(1)\nor\n38 CFR 4.16(b)\nif a(n)\nunusual or exceptional disability picture, with such related factors as marked interference with employment or frequent periods of hospitalization, renders the schedular evaluation inadequate for\nan individual disability, or\ntotal rating cannot be assigned solely because\nthe minimum schedular requirements of\n38 CFR 4.16\nare not met, and\na total rating is considered warranted.\nImportant\n:  ROs are only required to refer claims for extra-schedular consideration when that issue, whether or not argued by the claimant, is reasonably substantiated by the evidence of record.\nReferences\n:  For more information on\n﻿\nthe procedure for referring claims to Compensation Service for extra-schedular consideration, see\nM21-1, Part V, Subpart ii, 3.D.3.d\n, and\nextra-schedular consideration, see\nLong v. Wilkie,\n33 Vet.App. 167 (2020)\nKing v. Shulkin\n, 29 Vet.App. 174 (2017)\nYancy v. McDonald\n, 27 Vet.App. 484 (2016)\nThun v. Peake\n, 22 Vet.App. 111 (2008), and\nAnderson v. Shinseki\n, 22 Vet.App. 423 (2009).\nV.ii.3.D.3.d\n.\nExtra-Schedular Evaluations Under 38 CFR 3.321(b)(1)\n38 CFR 3.321(b)(1)\nprovides for referral for extra-schedular consideration based on the impact of a single disability.\nRefer a claim to the Compensation Service for a determination on whether an extra-schedular rating may be assigned when\nboth\nof the following criteria are met:\nthe established schedular criteria are inadequate to describe the severity and symptoms of the claimant’s disability,\nand\nthere are other indications of an exceptional or unusual disability picture, such as marked interference with employment or frequent periods of hospitalization.\nNotes\n:\nDo not routinely refer a claimant’s request for extra-schedular consideration to Compensation Service.  When a claimant requests extra-schedular consideration for an SC disability, only refer the claim if the referral criteria specified above are met.\nDo not dismiss the potential for extra-schedular referral based solely on the availability of a higher schedular disability evaluation.  The availability of a higher schedular rating is irrelevant in determining whether a request for extra-schedular evaluation is warranted unless the disability is evaluated as 100-percent disabling.  A disability may be considered for extra-schedular evaluation when less than the maximum available schedular evaluation is assigned as long as all other criteria for referral, as discussed above, have been met.\nWhen the schedular rating criteria contemplates the symptoms necessitating the use of assistive devices as well as the severity of those symptoms, referral for extra-schedular consideration under\n38 CFR 3.321(b)(1)\nis not warranted based solely on the use of assistive devices.\nReferences\n:  For more information on\nwhen to address the issue of entitlement to an extra-schedular evaluation under\n38 CFR 3.321(b)(1)\nin a rating decision, see\nVAOPGCPREC 6-1996\n, and\nthe relevance of the use of assistive devices in extra-schedular consideration, see\nSpellers v. Wilkie\n, 30 Vet.App. 211 (2008).\nV.ii.3.D.3.e\n.\nProcedure for Referring Claims for Extra-Schedular Consideration\nFollow the steps in the table below when referring claims for extra-schedular consideration under either\n38 CFR 3.321(b)(1)\nor\n38 CFR 4.16(b)\n.\nStep\nAction\n1\nComplete the appropriate memorandum as shown in\nM21-1, Part V, Subpart ii, 3.D.3.g\nor\nh\n.\nNote\n:  When referring a claim to Compensation Service for consideration of\nboth\n38 CFR 3.321(b)(1)\nor\n38 CFR 4.16(b)\n, the request may be submitted under the same memo as long as the memo fully discusses both extra-schedular provisions and provides recommendations for both.\n2\nObtain the required signatures on\nVA Form 21-0961, Rating Decision/Administrative Decision/Formal Finding/Statement of the Case (SOC)/Supplemental Statement of the Case (SSOC) (Electronic Signatures)\n.\n3\nUpload the memorandum and all other relevant documents to the Veteran’s electronic claims folder.\n4\nUse the table below to refer the claim to Compensation Service for extra-schedular consideration.\nIf the claim is …\nThen …\nprocessed in the National Work Queue (NWQ) environment\nassign the\nCompensation Service Review – Extraschedular\nspecial issue indicator to the relevant contention(s), and\nCompensation Service Case Review\ntracked item in accordance with the\nNWQ Phase 1 &2 Playbook\nto ensure proper routing to Compensation Service.\nnot processed in the NWQ environment\nassign the\nCompensation Service Review – Extraschedular\nspecial issue indicator to the relevant contention(s), and\nCompensation Service Case Review\ntracked item, and\nmanually broker the end product (EP) to\nCompensation Service (Washington DC)\n.\nReference\n:  For more information on manually brokering EPs, see the\nVBMS Core User Guide\n.\nReference\n:  For more information on\nassigning special issue indicators and tracked items, see\nM21-1, Part III, Subpart i, 2.F\n, and\nthe\nVBMS Core User Guide\n.\nV.ii.3.D.3.f\n.\nExtra-Schedular Consideration in Pension Claims\nIn pension claims, consider the issue of entitlement to an extra-schedular evaluation under\n38 CFR 3.321(b)(2)\nwhenever a Veteran fails to meet the schedular requirements for permanent and total (P&T) disability.  If approval is recommended, forward the rating decision and claims folder to the Veterans Service Center Manager, Pension Management Center Manager, or designee for signature.\nV.ii.3.D.3.g\n.\nExhibit 1:  38 CFR 3.321(b)(1) Referral Memorandum\nThis exhibit contains a sample of the memorandum completed for\n38 CFR 3.321(b)(1)\nreferrals.\nDEPARTMENT OF VETERANS AFFAIRS\n[RO Name\nRO Address]\n[Date]\nDirector                                                           In Rely Refer To:\nCompensation Service (214D)\n[RO #]\nDepartment of Veterans Affairs\n[File Number]\nCentral Office\n[Veteran’s Name]\n810 Vermont Ave. NW\nWashington, DC 20420\nSUBJECT:\nAdministrative Review for Entitlement to Increased Evaluation in Accordance with 38 CFR § 3.321(b)(1)\nBACKGROUND INFORMATION:  [List service information, such as branch, dates, and place(s) of service.]\nSTATEMENT OF ISSUE:  [State specific review requested, including any relevant time period and whether the issue is part of a Board of Veterans’ Appeals (BVA) remand.]\nExample\n:\nReview for entitlement to an increased evaluation on an extra-schedular basis for bilateral hearing loss\n.\nEVIDENCE:  [List the evidence used for this review.]\nExample\n:\nRating decision dated August 1, 2008\nBVA decision/remand dated November 1, 2015\nVA examinations dated June 7, 2008, July 10, 2010, September 12, 2015, and June 20, 2016\nDISCUSSION:  [Discuss medical evidence in detail for each SC disability related to the request for all pertinent time periods, to include medical evidence found within the file and the BVA remand.]\nExample\n:\nService connection has been established for bilateral hearing loss.  This condition has been evaluated at zero percent disabling since January 6, 2008.  The Veteran is requesting an increased evaluation for this condition. BVA remanded this issue on November 1, 2015, and directed that the case be referred for consideration of entitlement to an increased evaluation on an extra-schedular basis from January 6, 2008, to present.\nVA examinations dated June 7, 2008, July 10, 2010, and September 12, 2015, document that the Veteran’s hearing loss has been appropriately evaluated at zero percent disabling for the time period of this review.  Speech recognition scores were 96% for the right ear and 94% for the left ear.\nOn June 20, 2016, another examination was performed.  Testing revealed a slight deterioration in the bilateral hearing loss; however this change is not sufficient to warrant an increased evaluation on a schedular basis.  Speech recognition scores remained at previous levels.  The examiner stated that the Veteran’s hearing loss would not preclude employment.  The examiner further stated that the Veteran would have some difficulty working in situations with a lot of background noise.\nEvidence shows that the Veteran attended college for two years and worked as an engineer following separation from service.  He retired from this position in January of 2012, after 23 years.  Evidence does not show that the bilateral hearing loss interfered with employment.\nExtra-schedular evaluations are assigned in cases where an exceptional or unusual disability picture is presented with such related factors as marked interference with employment or frequent periods of hospitalization that renders application of regular rating schedular standards impractical. No unusual or exceptional disability pattern has been demonstrated that would render application of the regular rating criteria as impractical.  The evidentiary record does not demonstrate that the symptomatology consistently associated with the service-connected bilateral hearing loss supports an increased evaluation on a schedular or extra-schedular basis for any time period.\nRECOMMENDATION:\n[Provide a recommendation, to include an effective date, if applicable.]\nExample\n:\nDeny an increased evaluation on an extra-schedular basis for bilateral hearing loss.\nSIGNATURES\n:\n[Document signatures on\nVA Form 21-0961\nby following procedures in M21-1, Part X, Subpart v, 1.C.3.e.]\nV.ii.3.D.3.h\n.\nExhibit 2:  38 CFR 4.16(b) Referral Memorandum\nThis exhibit contains a sample of the memorandum completed for\n38 CFR 4.16(b)\nreferrals.\nDEPARTMENT OF VETERANS AFFAIRS\n[RO Name\nRO Address]\n[\nDate\n]\nDirector                                                           In Rely Refer To:\nCompensation Service (214D)                          [\nRO #\n]\nDepartment of Veterans Affairs                        [\nFile Number\n]\nCentral Office                                                   [\nVeteran’s Name\n]\n810 Vermont Ave. NW\nWashington, DC 20420\nSUBJECT:\nAdministrative Review for Entitlement to Total Disability Rating Based on Individual Unemployability (TDIU) in Accordance with 38 CFR 4.16(b)\nBACKGROUND INFORMATION:  [List service information, such as branch, dates, and place(s) of service.]\nSTATEMENT OF ISSUE:  [State specific review requested, including any relevant time period and whether the issue is part of a BVA remand.]\nExample\n:\nReview for entitlement to TDIU benefits on an extra-schedular basis for the period June 20, 2016, to May 1, 2017\n.\nEVIDENCE:  [List the evidence used for this review]\nExample\n:\nRating decision dated April 15, 2016\nBVA remand dated June 1, 2017\nVA Form 21-8940, Veteran's Application for Increased Compensation Based on Unemployability, received January 12, 2016\nTranscript of hearing, dated May 19, 2017\nVA examinations dated December 2012, March 2014, and May 2016\nSocial Security Administration (SSA) disability transmittal sheet, dated January 30, 2016\nDISCUSSION:  [Discuss medical evidence in detail for each SC disability related to the request for all pertinent time periods, to include medical evidence found within the file and the BVA remand.]\nExample\n:\nService connection has been established for three conditions.  Posttraumatic stress disorder (PTSD) was evaluated at 30 percent disabling effective January 2, 2013, and increased to 50 percent disabling effective January 3, 2016; arthritis of the right knee has been evaluated at 10 percent disabling since June 5, 2010, and bilateral hearing loss has been evaluated at zero percent disabling since June 5, 2010.  The combined evaluation for compensation was 10 percent effective June 5, 2010; 40 percent effective January 2, 2013, and 60 percent effective January 3, 2016.  BVA remanded this issue on January 1, 2017, and directed that the case be referred for entitlement to IU benefits on an extra-schedular basis from January 2, 2013, to present date.\nEvidence from SSA shows that the Veteran was found to be entitled to SSA disability benefits in June of 2013.  The primary condition utilized to make that decision was disorders of the spine, and the secondary condition was disorders of the knee.\nEvidence shows that the Veteran attended college for four years and worked as an automobile salesperson following separation from service.  He retired from this position in January of 2012, after 26 years.  Evidence does not show that the service-connected conditions interfered with employment.\nVA psychiatric examinations performed in December of 2012, March of 2014, and May of 2016, demonstrate that the Veteran’s PTSD has deteriorated since 2013.  The Veteran has never been hospitalized for PTSD, and records show no therapy sessions prior to January of 2016.  The Veteran took prescription medication prescribed by his family doctor until December of 2015, when he first started treatment with a psychiatrist.  Evidence shows no hallucinations, delusions, or suicidal or homicidal ideations at any time.  The Veteran’s depression and anxiety (symptoms of PTSD) increased in severity in late 2015.  He started having occasional panic attacks and having difficulty getting along with family members and friends.  He started to isolate himself more often and had difficulty sleeping most nights.  Evidence does not include any medical opinions indicating that the PTSD interfered with prior employment or would prevent employment at any time.\nA VA musculoskeletal examination performed in March of 2014, revealed full motion of the right knee with pain.  X-ray evidence revealed arthritis.  No instability of the knee was found.  The Veteran reported pain with extended periods of walking and standing.  He takes over-the-counter pain medication as needed for knee pain.  He does not use a cane or other ambulatory aids.  No surgery has been performed on the right knee.\nA VA examination performed in March of 2014 revealed a mild bilateral hearing loss.  The Veteran was able to hear well during the examination.  His speech discrimination scores were 98% in each ear.  The examiner stated that the hearing loss would not affect employment.\nIt is the established policy of the Department of Veterans Affairs that all Veterans who are unable to secure and follow a substantially gainful occupation by reason of service-connected disabilities shall be rated totally disabled. None of the available evidence supports the Veteran’s contention that any of his service-connected disabilities or a combination of the effects of the disabilities prevents all types of gainful activity.\nRECOMMENDATION:\n[Provide a recommendation, to include an effective date, if applicable.]\nExample\n:\nGrant entitlement to TDIU on an extra-schedular basis effective June 20, 2017.\nSIGNATURES\n:\n[Document signatures on\nVA Form 21-0961\nby following procedures in M21-1, Part X, Subpart v, 1.C.3.e.]\n4\n.\nP&/T Evaluations\nIntroduction\nThis topic contains information on the rating determination for DEA under 38 U.S.C. Chapter 35, including\ndefinition of a\ntotal disability\n, and\npermanent disability\nrequirement for permanence\nevidentiary threshold for establishing permanence\nestablishing permanence for chronic, progressive disabilities\ndate of P&T disability\nwhen claimed or raised as a subordinate issue\n, and\nupon cancellation or dismissal of review examination control\nP&T reasons for decision\naddressing the P&T status of disabilities normally requiring a review examination\n, and\ngranting P&T without Dependents' Educational Assistant (DEA)\n.\nChange Date\nJuly 21, 2022\nV.ii.3.D.4.a\n.\nDefinition:  Total Disability\nTotal disability\nmeans\nschedular or extraschedular evaluations of 100 percent under, or by analogy to, any DC in\n38 CFR Part 4\na combined evaluation of 100 percent, or\na total evaluation on the basis of IU.\nReference\n:  For more information on a total disability evaluation for the loss of paired organs or extremities under\n38 U.S.C. 1160\n, see\nKimberlin v. Brown\n, 5 Vet.App. 174 (1993).\nV.ii.3.D.4.b\n.\nDefinition: Permanent Disability\nPermanent disability\nmeans disabling manifestations reasonably certain to continue throughout the lifetime of the individual.\nReference\n:  For more information on permanent disability, see\n38 U.S.C. 3501\n38 CFR 3.340\n, and\n38 CFR 4.15\n.\nV.ii.3.D.4.c\n.\nRequirement for Permanence\nThe mere existence of a total disability evaluation is not sufficient to establish a P&T evaluation. The evidence must establish permanence of the total evaluation, as discussed in\nM21-1, Part V, Subpart ii, 3.D.4.d\n. Total evaluations assigned under the following provisions are temporary:\nprestabilization (\n38 CFR 4.28\n)\nextended VA hospitalization (\n38 CFR 4.29\n)\nconvalescence (\n38 CFR 4.30\n), and\nany DC that provides for a limited period of total disability for convalescence such as joint replacements or cardiac procedures.\nExceptions\n:\nVeterans who are considered P&T disabled prior to the assignment of a 100-percent evaluation under a DC with a limited duration and future examination will be considered permanently disabled during the total evaluation.  The status of permanency is reconsidered following completion of the examination.\nExample\n:  A Veteran who is considered permanently and totally disabled because of a heart disorder based on metabolic equivalents (METs) undergoes cardiac transplantation surgery.  The Veteran would continue to be considered P&T disabled for the duration of the one-year convalescent period under\n38 CFR 4.104, DC 7019\n.\nA temporary total evaluation on the date of death will establish a P&T disability.  Total disability did persist from the date assigned until the end of the person’s life.\nV.ii.3.D.4.d\n.\nEvidentiary Threshold for Establishing Permanence\nPermanence of a total disability evaluation may be established when the evidence of record clearly establishes that a disability is expected to continue at its current level of severity.  However, clear and specific evidence is not required to establish permanence.\nWhen the evidence of record does not clearly or specifically show that the total disability will continue but\nalso\ndoes not show\nthat a reexamination to ascertain improvement is warranted pursuant to\n38 CFR 3.327(b)(2)\n, concede permanence of the evaluation based on a reasonable certainty that improvement is not likely.\nThe following fact patterns demonstrate scenarios in which P&T disability is established based on the preponderance of the evidence of record.\nEvidence at the time of evaluation affirmatively shows that the total disability will continue for the remainder of the person’s life.\nEvidence at the time of evaluation does not specifically support that the total disability will continue for the remainder of the person’s life but does not show that the condition is likely to improve pursuant to\n38 CFR 3.327(b)(2)\n.  In such cases, a future examination control is inappropriate so the total disability rating is static; in the absence of re-evaluation, total disability is likely to continue for the remainder of the person’s life.\nAt or before the time of maturation of a future examination diary pertinent to the continuation of total disability, the future examination control is canceled because\nthe future exam control was erroneous under\n38 CFR 3.327(b)(2)\n, or\nevidence is received that changes the prior assessment that the condition was likely to improve.\nTotal disability has been in effect for 20 or more years per\n38 CFR 3.951\n.  In such cases, the total disability is protected and is therefore static and will continue for the remainder of the person’s life.\nA qualifying individual with total disability dies. In such cases, the total disability is permanent because it persisted until the end of the person’s life.\nNotes\n:\nThe evidentiary threshold provided in\n38 U.S.C. 3501(a)(8)\nto establish permanence is that there must be a\nreasonable certainty\nthat the level of impairment will continue throughout the life of the disabled person.  This threshold means that there is more than an approximate balance of evidence indicating that the level of impairment will continue indefinitely.\nFor historical purposes, a 100-percent evaluation under the 1925 rating schedule also meets the criteria of a “total disability, permanent in nature,” for DEA, per\n38 CFR 3.952\n.\nReference\n:  For more information on the definition of static disability, see\nM21-1, Part IV, Subpart ii, 2.B.2.b\n.\nV.ii.3.D.4.e\n.\nEstablishing Permanence for Chronic, Progressive Disabilities\nWhen evidence indicates that cancer or other similarly chronic and progressive disabilities are not expected to improve, concede permanence for the disability evaluation.  Examples of indicators suggesting the likelihood that the disability status is permanent include but are not limited to\na prescription for palliative treatment only for a cancer diagnosis\na prescription for hospice care, or\nan indicator in medical evidence that the condition is considered terminal.\nV.ii.3.D.4.f\n.\nDate of P&T Disability When Claimed or Raised as a Subordinate Issue\nBasic eligibility based on a P&T SC disability is only established when all criteria (i.e., SC, total disability, and permanence of disability) are met.\nTherefore,  the date of P&T disability is the\nlater of\nthe date of claim,\nor\nthe date that the final criterion is factually established.\nNotes\n:\nIf medical evidence reviewed in connection with a claim portrays an increase in SC disability, warranting a finding of permanence, establish the P&T evaluation and apply the effective date provisions of whichever of the following is more applicable/appropriate:\n38 CFR 3.400(o)(2)\n, or\n38 CFR 3.2500(h)\n.\nWhen results of a VA-initiated review/future examination portray permanence of an individual or combined total disability evaluation, establish basic eligibility to a P&T evaluation as of the date the examination was performed.\nAttribute examination or other findings dated after the date of claim back to the date of claim unless there is specific evidence there was a change to total disability or to permanece of disability between the date of claim and the date of the evidence.\nExample\n:  A VA examination finding that contains an opinion on permanence of disability would be attributed to the date of claim unless there was specific evidence dated on or after the date of claim, and prior to the VA examination date, indicating that the total disability was likely to improve, in which case the date of permanence would be the date of examination.\nReferences\n:  For more information on\neffective dates, see\nM21-1, Part V, Subpart ii, 4.A\n, and\nentitlement to Dependents' Educational Assistance (DEA) arising from P&T evaluations, see\nM21-1, Part XIII, Subpart i, 1.A\n.\nV.ii.3.D.4.g\n.\nDate of P&T Disability Upon Cancellation or Dismissal of Review Examination Control\nUse the table below to determine the date of P&T disability when\nthere is total disability but no indication of permanence based on an established future or review examination control, and\na P&T determination is subsequently necessitated by one of the following actions:\ncancellation of the future examination control prior to maturation, or\ndetermination that a review examination should not be scheduled at the time the future examination control matures.\nWhen the action is based on ...\nThen ...\na determination that the examination control was initially set up in\nerror\nExample\n:  In violation of\n38 CFR 3.327(b)(2)\n, a future examination control is set for a condition, like amytrophic lateral sclerosis (ALS), that can only be rated at 100 percent and is, by its nature, permanent.\nset the date of P&T disability\nas if the future examination control were never established\n.\nExplanation\n:  The examination control was erroneous; therefore, the condition was static at the time of the rating decision establishing SC.\na difference in judgment rather than a specific error in the initial future examination control\nExample\n:  The rating activity determines, prior to scheduling, that a review examination should not be scheduled as planned because the conclusion of likely future improvement used to set the future examination control was not well justified by the facts.\nuse the\ndate of review\nfor the date of P&T disability.\nExplanation\n:  This is essentially a new determination of permanency on the date of review caused by reexamination of the facts.\nnew evidence that changes the prior assessment that the total disability is likely to improve, as indicated by a future examination control\nuse the\ndate that the new evidence is received\nfor the date of P&T disability.\nException\n:  When the new evidence portraying disability permanence is dated within one year prior to the date of the current review, apply the effective date provisions of\n38 CFR 3.400(o)(2)\n.\nReferences\n:  For more information on effective dates\nfor increased compensation, see\nM21-1, Part V, Subpart ii, 4.A.5\n, and\nbased on historical\n38 CFR 3.157\n, see\nM21-1, Part V, Subpart ii, 4.B.1\n.\nV.ii.3.D.4.h\n.\nP&T Reasons for Decision\nRating decisions establishing P&T status must provide\nthe basis for the decision, and\na discussion of the evidence supporting the decision.\nV.ii.3.D.4.i\n.\nAddressing the P&T Status of Malignancies\nVBMS-R’s system-generated language for evaluating totally disabling SC malignancies or other disabilities normally requiring a review examination usually includes reference to the scheduling of a mandatory review examination intended to determine recurrence or residual disability.\nWhen, however, P&T status of the SC disability has been conceded in light of the guidance in\nM21-1, Part V, Subpart ii, 3.D.4.e\n, edit the rating decision narrative by replacing the system-generated text displayed in the left column of the table below with the text displayed in the right column.\nVBMS-R System-Generated Text\nReplacement Text\nA rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure.  Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.  Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of 38 CFR §3.105(e).  If there has been no local recurrence or metastasis, you will be rated on residuals.\nThe medical evidence shows that permanence of this disability has been established.  Consequently, no future VA examination will be requested.\nReferences\n:  For more information on\nassigning P&T evaluations for amyloid light chains amyloidosis, see\nM21-1, Part V, Subpart iii, 9.2.a\n, and\nhistorical assignment of P&T evaluations for multiple myeloma and chronic lymphocytic leukemia, see\nM21-1, Part V, Subpart iii, 9.2.f\n.\nV.ii.3.D.4.j\n.\nGranting P&T without DEA\nWhen a P&T evaluation is established, if eligibility for DEA is not being established as an ancillary benefit in the same rating decision (for example, when eligibility for DEA has been granted in a prior decision or is not warranted for a grant of benefits under\n38 U.S.C. 1151\n), modify the rating narrative text to provide a discussion of only the permanence determination unless a decision is specifically required for DEA.\n5\n.\nPrinciples of Disability Evaluation for Specific Conditions\nIntroduction\nThis topic contains information about evaluating specific conditions or circumstances, including\nevaluating malignant neoplasms and associated impairments\nexamples of evaluating diagnosed disabilities due to malignant neoplasms\nevaluating an SC disability eliminated by NSC amputation\n, and\nconsidering recurrent or refractory symptoms\n.\nChange Date\nSeptember 15, 2021\nV.ii.3.D.5.a\n.\nEvaluating Malignant Neoplasms and Associated Impairments\nUse the table below to determine whether a symptom or condition associated with an active malignant neoplasm may be separately evaluated during the period in which a 100-percent evaluation is warranted for the active malignant neoplasm.\nIf the condition is a ...\nThen ...\npurely symptomatic complaint arising from the malignant neoplasm\ndo not assign a separate evaluation.\nsymptom arising from treatment for the malignant neoplasm\ndo not assign a separate evaluation.\ndiagnosed disability deemed to be caused by or related to the malignant neoplasm\napply\n38 CFR 4.14\nto determine whether the symptoms of the diagnosed disability are considered in the 100-percent evaluation for the malignant neoplasm\nreview the evaluation criteria for both conditions and other applicable provisions to determine whether separate evaluations are allowable, and\nif the pyramiding rule in\n38 CFR 4.14\nhas not been violated and separate evaluations are otherwise allowable, assign a separate evaluation.\nNote\n:  When the DC for the active malignancy is directive as to how to evaluate residuals of the cancer, conditions or symptoms that\nwould be rated as residuals should not be assigned a separate evaluation during the pendency of the 100-percent evaluation for the active malignancy, and\nwould not be rated as residuals may be granted separately and concurrently with the 100-percent evaluation.\nmetastatic malignant neoplasm affecting a different body system than is affected by the primary SC neoplasm\nassign a separate evaluation.\nNote\n:  For the purpose of determining entitlement to SMC at the statutory housebound rate under\n38 CFR 3.350(i)(1)\n, carcinoma that has metastasized and involves two different body systems would generally be considered separate and distinct.  The fact that there is an etiological relationship does not preclude considering the impact and effects as separate and distinct.\nmetastatic malignant neoplasm affecting the same body system as is affected by the primary SC neoplasm\ndo not assign a separate evaluation.\nNote\n:  This guidance is applicable when language within a particular DC refers to\nmalignant neoplasms\nin plural.\nNote\n:  If doubt arises as to the medical cause or association of any symptoms or diagnosis, a medical opinion should be requested for clarification.\nReferences\n:  For more information on\nassignment of separate evaluations for individual findings, see\nM21-1, Part V, Subpart ii, 3.D.2.b\n, and\nentitlement to SMC based on housebound status, see\nM21-1, Part VIII, Subpart iv, 4.A.10\n.\nV.ii.3.D.5.b\n.\nExamples of Evaluating Diagnosed Disabilities Due to Malignant Neoplasms\nExample 1\n:  SC for anxiety disorder claimed and diagnosed as secondary to active lung cancer may be granted and separately evaluated.\nExample 2\n:  A Veteran is SC with a 100-percent evaluation assigned for active renal cancer and undergoes a nephrectomy as a part of the treatment for the renal cancer.\n38 CFR 4.115b, DC 7528\ndirects that renal cancer is evaluated as active malignancy and its residuals are evaluated based on either voiding dysfunction or renal dysfunction.  Since a nephrectomy is evaluated either with the minimum compensable evaluation or as renal dysfunction under\n38 CFR 4.115b, DC 7500\n, the rating schedule recognizes that renal dysfunction is within the predominant symptomatology of both disabilities.  Since both criteria contemplate renal dysfunction, the nephrectomy cannot be separately evaluated.\nExample 3\n:  A Veteran is SC with a 100-percent evaluation assigned for active renal cancer.  The Veteran is diagnosed with recurrent pyelonephritis which is characterized by symptoms of recurrent urinary tract infection.  The pyelonephritis is identified as a complication of the renal cancer.\n38 CFR 4.115b, DC 7528\ndirects that renal cancer is evaluated as active malignancy and its residuals are evaluated based on either voiding dysfunction or renal dysfunction.  Since the pyelonephritis is characterized by recurrent urinary tract infection, which is not considered within the criteria for evaluating malignant neoplasms of the genitourinary system, a separate evaluation may be assigned under\n38 CFR 4.115b, DC 7504\nutilizing the urinary tract infection symptoms.\nExample 4\n:  A Veteran is SC with a 100-percent evaluation assigned under\n38 CFR 4.114, DC 7343\nfor active colon cancer.  The Veteran sustained a nerve injury during surgery for the colon cancer resulting in impairment of anal sphincter control with incontinence.  Since the symptoms of impairment of sphincter control with incontinence are due to a separately diagnosed disability (the nerve injury), pyramiding rules are not violated, and\n38 CFR 4.114\ndoes not prohibit separate evaluations for these coexisting digestive system disabilities, a separate evaluation may be assigned for the nerve injury with impairment of sphincter control under\n38 CFR 4.114, DC 7332\n.\nExample 5\n:  A Veteran is SC with a 100-percent evaluation assigned under\n38 CFR 4.115b, DC 7528\n.  A VA examination revealed a diagnosis of erectile dysfunction due to the prostate cancer.  Since\n38 CFR 4.115b, DC 7528\ndirects that prostate cancer is evaluated based on residuals consisting of voiding dysfunction or urinary tract infection, SC for the erectile dysfunction should be established concurrently with the 100-percent evaluation.\nV.ii.3.D.5.c\n.\nEvaluating an SC Disability Eliminated by NSC Amputation\nWhere an NSC cause necessitates amputation of an extremity resulting in elimination of an SC disability distal to the site of the amputation, do not sever SC for or reduce the evaluation of the SC disability.\nV.ii.3.D.5.d\n.\nConsidering Recurrent or Refractory Symptoms\nMany evaluation criteria require consideration of the frequency of occurrence of symptoms.  Two descriptions used throughout the rating schedule for frequency of occurrence are\nrefractory\nand\nrecurrent\n.\nRecurrent\ndescribes signs, symptoms, or a disease that returns after a period of remission (or a period of time during which the symptoms could not be detected).\nRefractory\ndescribes a disease, condition, or symptoms that do not respond or are resistant to treatment.\nExample\n:  The evaluation criteria for human immunodeficiency virus (HIV)-related illness at\n38 CFR 4.88b, DC 6351\nutilizes recurrent symptoms for the 30-percent evaluation and refractory symptoms for the 60-percent evaluation.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000180488\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section C - Reviewing Diagnoses\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180488/M21-1-Part-V-Subpart-ii-Chapter-3-Section-C-Reviewing-Diagnoses\">&lt;-- Previous Section</a>  <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">Next Section --&gt;</a></span></span></p><h2 class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></h2><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This section contains the following topics: </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 495px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 has the topic number and column 2 has the topic title.\" width=\"495\"><thead><tr><th scope=\"col\" style=\"width: 65px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><strong><strong>Topic</strong></strong></span></span></div></th><th scope=\"col\" style=\"width: 333px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><strong><strong>Topic Name</strong></strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 65px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1</span></span></div></td><td style=\"width: 333px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1\" target=\"_self\">Selecting Diagnostic Codes (DCs)</a></span></span></div></td></tr><tr><td style=\"width: 65px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">2</span></span></div></td><td style=\"width: 333px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2\" target=\"_self\">Determining a Disability Evaluation Based on Rating Schedule Criteria</a></span></span></div></td></tr><tr><td style=\"width: 65px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">3</span></span></div></td><td style=\"width: 333px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3\" target=\"_self\">Extra-schedular Evaluations</a></span></span></div></td></tr><tr><td style=\"width: 65px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">4</span></span></div></td><td style=\"width: 333px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4\" target=\"_self\">Permanent and Total (P&amp;T) Evaluations</a></span></span></div></td></tr><tr><td style=\"width: 65px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">5</span></span></div></td><td style=\"width: 333px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#5\" target=\"_self\">Principles of Disability Evaluation for Specific Conditions</a></span></span></div></td></tr></tbody></table></td></tr></tbody></table><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><h2 class=\"ng-scope\"></h2><h2 class=\"ng-scope\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\">1<a id=\"1\" name=\"1\">.</a>  Selecting DCs</span></span></h2><div class=\"ng-scope\"> <br/> </div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">This topic includes information to supplement the regulatory provisions for selection of  DCs to evaluate disabilities in the <em>Department of Veterans Affairs (VA) Schedule for Rating Disabilities</em>, including</span></span></div><ul><li><div><a href=\"#1a\" target=\"_self\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">choosing from multiple possible DCs</span></span></a></div></li><li><div><a href=\"#1b\" target=\"_self\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">use of hyphenated DCs</span></span></a></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#1c\" target=\"_self\">using analogous codes</a></span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#1d\" target=\"_self\">when to avoid rating by analogy</a></span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#1e\" target=\"_self\">impact of a change in DC</a>, and</span></span></span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#1f\" target=\"_self\">handling a change in diagnosis</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">May 29, 2025</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.1.a<a id=\"1a\" name=\"1a\">.</a>  Choosing From Multiple Possible DCs </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Diagnostic Codes (DCs) must be carefully selected and reasons for selection given if two or more are applicable.  When multiple DCs apply to a given disability, consider</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">whether separate evaluations are warranted, and/or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">which DC will result in the most advantageous outcome for the claimant.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining whether separate evaluations are warranted, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2b\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.2.b</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&amp;mc=true&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a></span></span></span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">providing the reason for selection of a DC in the rating decision, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000180523\" articlename=\"M21-1, Part V, Subpart iv, Chapter 1, Section A - Completing the Rating Decision Narrative\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180523/M21-1-Part-V-Subpart-iv-Chapter-1-Section-A-Completing-the-Rating-Decision-Narrative\">M21-1, Part V, Subpart iv, 1.A.6.B</a>, and</span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000071686\" articlename=\"Suttman v. Brown, May 18, 1993, 5 Vet.App. 127 (1993)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000071686/Suttman-v-Brown-May-18-1993-5-VetApp-127-1993\"><em>Suttman v. Brown</em></a>, 5 Vet.App. 127 (1993), and</span></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">procedures for entering DCs in the Veterans Benefits Management System-Rating (VBMS-R), see <a articleid=\"554400000180525\" articlename=\"M21-1, Part V, Subpart iv, Chapter 1, Section C - Coded Conclusion\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180525/M21-1-Part-V-Subpart-iv-Chapter-1-Section-C-Coded-Conclusion\">M21-1, Part V, Subpart iv, 1.C.2</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.1.b<a id=\"1b\" name=\"1b\">.</a>  Use of Hyphenated DCs </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Hyphenated DCs may be utilized for diseases or injuries.  The use of a hyphenated DC is not intended to substitute for appropriate assignment of separate evaluations for different disabilities arising from a single injury. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on the</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">use of hyphenated DCs, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&amp;mc=true&amp;node=se38.1.4_127&amp;rgn=div8\" target=\"_blank\">38 CFR 4.27</a></span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180525\" articlename=\"M21-1, Part V, Subpart iv, Chapter 1, Section C - Coded Conclusion\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180525/M21-1-Part-V-Subpart-iv-Chapter-1-Section-C-Coded-Conclusion\">M21-1, Part V, Subpart iv, 1.C.2.c and d</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><a articleid=\"554400000014887\" articlename=\"Tropf v. Nicholson, Aug 24, 2006, 20 Vet.App. 317\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014887/Tropf-v-Nicholson-Aug-24-2006-20-VetApp-317\">Tropf v. Nicholson</a></em>, 20 Vet.App. 317 (2006)</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">use of hyphenated DCs for qualifying disabilities associated with service in Southwest Asia, see <a articleid=\"554400000177440\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 1, Section C - Rating Presumptive Service Connection (SC) Claims for Persian Gulf Veterans\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177440/M21-1-Part-VIII-Subpart-ii-Chapter-1-Section-C-Rating-Presumptive-Service-Connection-SC-Claims-for-Persian-Gulf-Veterans\">M21-1, Part VIII, Subpart ii, 1.C.2.b</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assignment of separate evaluations for individual manifestations of a disease or injury, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2b\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.2.b</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000066775\" articlename=\"Esteban v. Brown, February 25, 1994, 6 Vet.App. 259 (1994)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000066775/Esteban-v-Brown-February-25-1994-6-VetApp-259-1994\"><em>Esteban v. Brown</em></a>, 6 Vet.App. 259 (1994). </span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">V.ii.3.D.1.c<a id=\"1c\" name=\"1c\">.</a>  Using Analogous Codes</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Use analogous codes to evaluate disabilities not listed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=eb7493eb29df5c572d488350d31b4925&amp;node=pt38.1.4&amp;rgn=div5\" target=\"_blank\">38 CFR Part 4</a><span style=\"color:blue\">,</span> the <i>Department of Veterans Affairs </i>(<i>VA) Schedule for Rating Disabilities</i>, based on</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">function(s) affected</span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">anatomical location, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">symptomatology.</span></span></div></li></ul><div><span style=\"font-family: Arial, Helvetica, sans-serif; font-size: 14px;\">These factors </span><b style=\"font-family: Arial, Helvetica, sans-serif; font-size: 14px;\"><i>must</i></b><span style=\"font-family: Arial, Helvetica, sans-serif; font-size: 14px;\"> be discussed in the rating decision </span><i style=\"font-family: Arial, Helvetica, sans-serif; font-size: 14px;\">Narrative</i><span style=\"font-family: Arial, Helvetica, sans-serif; font-size: 14px;\"> when a disability is evaluated under an analogous DC. </span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">When a claimant (or representative) requests a disability be evaluated under a specific DC and the claims processor chooses to evaluate the disability under an alternative DC, the rating decision <i>Narrative</i> <b><i>must</i></b> explain (in sufficient detail) why the particular analogous DC was selected and why the requested DC was not appropriate to evaluate the Veteran’s disability.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">In cases where there is no other reasonable alternative DC for analogous purposes, other than the selected analogous DC, the claims processor should indicate this in the <i>Narrative</i>.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>References</i></b>:  For more information on analogous ratings, see</span></span></div><ul><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/section-4.20\" target=\"_blank\">38 CFR 4.20</a></span></span></li><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a articleid=\"554400000180525\" articlename=\"M21-1, Part V, Subpart iv, Chapter 1, Section C - Coded Conclusion\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180525/M21-1-Part-V-Subpart-iv-Chapter-1-Section-C-Coded-Conclusion\">M21-1, Part V, Subpart iv, 1.C.2</a></span></span></li><li><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a articleid=\"554400000294454\" articlename=\"Lendenmann v. Principi, 3 Vet. App. 345 (1992)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000294454/Lendenmann-v-Principi-3-Vet-App-345-1992\"><i>Lendenmann v. Principi</i></a>, 3 Vet.App. 345 (1992), and</span></span></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><em><a articleid=\"554400000301679\" articlename=\"Webb v. McDonough, 71 F.4th 1377 (2023)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000301679/Webb-v-McDonough-71-F4th-1377-2023\">Webb v. McDonough</a></em>, 71 F.4th 1377 (Fed.Cir. 2023).</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.1.d<a id=\"1d\" name=\"1d\">.</a>  When to Avoid Rating by Analogy </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When a condition is specifically listed in the rating schedule, it may not be rated by analogy.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When there is a diagnosis of two separate conditions, apply the DC(s) that specifically pertains to the listed conditions and determine the appropriate disability evaluations. </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on analogous ratings, see </span></span></span></span></span></span><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a articleid=\"554400000056856\" articlename=\"Copeland v. McDonald, Jun 25, 2015, 27 Vet.App. 333 (2015)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000056856/Copeland-v-McDonald-Jun-25-2015-27-VetApp-333-2015\"><em>Copeland v. McDonald</em></a>, 27 Vet.App. 333 (2015)</span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.1.e<a id=\"1e\" name=\"1e\">.</a>  Impact of a Change in DC</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Service connection (SC) of a disability is not severed when the site of a disability or the DC associated with it is corrected to more accurately determine the benefit to which a Veteran may be entitled.  The diagnosis or site of the existing service-connected (SC) condition may be corrected to accurately reflect the actual anatomical location of the injury or disease resulting in the Veteran’s disability, provided the redesignation does not result in severance of SC for the disability in question.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">However, a change in DC cannot serve to reduce a protected disability evaluation where the symptoms upon which the evaluation was based are no longer present. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">A change of diagnosis shown on examination or in other medical evidence must be reconciled to determine whether the underlying disability is the same condition or a progression of the condition that was previously diagnosed under a different diagnosis or whether a new disability, unrelated to the prior diagnosis, is being addressed.</span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 1</em></strong>:  A Veteran is SC for gunshot wound (GSW) of the right thigh muscle group (MG) XIII under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=73dbd1ea57aace04181d2e02e631f64b&amp;mc=true&amp;node=se38.1.4_173&amp;rgn=div8\" target=\"_blank\">38 CFR 4.73, DC 5313</a> with a 10-percent evaluation assigned based on moderate impairment.  Subsequent evidence showed that the GSW actually impacted only MG XV, which is evaluated under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=73dbd1ea57aace04181d2e02e631f64b&amp;mc=true&amp;node=se38.1.4_173&amp;rgn=div8\" target=\"_blank\">38 CFR 4.73, DC 5315</a> and that there was never an injury to or impairment of MG XIII.  In this situation, since the correction of DC serves only to correct the site of the impairment and does not serve to effectively sever SC for an otherwise properly established disability, the change in DC is warranted.</span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 2</em></strong>:  A Veteran is SC under <a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=0a84b89a963326c38da056b1f6b17b0a&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a, DC 5257</a> for mild instability of the left knee shown on examination.  The evaluation has been in place for over 20 years and is protected under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&amp;mc=true&amp;node=se38.1.3_1957&amp;rgn=div8\" target=\"_blank\">38 CFR 3.957</a>.  A claim for increase is received.  The resultant examination shows no instability of the left knee but does show arthritis and pain related to the SC injury.  In this situation, the 10-percent evaluation assigned under <a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=0a84b89a963326c38da056b1f6b17b0a&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a, DC 5257</a> may not be reduced or eliminated.  However, since there are separately compensable disabilities shown in the record, a separate evaluation for arthritis may be assigned under <a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=0a84b89a963326c38da056b1f6b17b0a&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a, DC 5010</a>.</span></span></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></span></span></span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the applicability of protection for</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">an SC evaluation under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&amp;mc=true&amp;node=se38.1.3_1951&amp;rgn=div8\" target=\"_blank\">38 CFR 3.951</a> when</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a DC is changed, see <a articleid=\"554400000177962\" articlename=\"M21-1, Part X, Subpart ii, Chapter 1, Section B - Protected Ratings\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177962/M21-1-Part-X-Subpart-ii-Chapter-1-Section-B-Protected-Ratings\">M21-1, Part X, Subpart ii, 1.B.1.k</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the condition has been evaluated with a single disability evaluation which is now being replaced by separate evaluation, see <a articleid=\"554400000177962\" articlename=\"M21-1, Part X, Subpart ii, Chapter 1, Section B - Protected Ratings\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177962/M21-1-Part-X-Subpart-ii-Chapter-1-Section-B-Protected-Ratings\">M21-1, Part X, Subpart ii, 1.B.1.l</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">SC under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&amp;mc=true&amp;node=se38.1.3_1957&amp;rgn=div8\" target=\"_blank\">38 CFR 3.957</a> when a DC is being changed or the site of a disability is being corrected, see <a articleid=\"554400000177962\" articlename=\"M21-1, Part X, Subpart ii, Chapter 1, Section B - Protected Ratings\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177962/M21-1-Part-X-Subpart-ii-Chapter-1-Section-B-Protected-Ratings\">M21-1, Part X, Subpart ii, 1.B.2.d</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">handling examination reports reflecting a change or conflict in diagnoses, see</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1a2181df37babc2b76f6ff912573b2e2&amp;mc=true&amp;node=se38.1.4_12&amp;rgn=div8\" target=\"_blank\">38 CFR 4.2</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180517\" articlename=\"M21-1, Part IV, Subpart i, Chapter 3, Section C - Insufficient Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180517/M21-1-Part-IV-Subpart-i-Chapter-3-Section-C-Insufficient-Examinations\">M21-1, Part IV, Subpart i, 3.C</a> </span></span></div></li></ul></li></ul><div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining whether a change in DC effectively results in severance of SC, see</span></span></span></span></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000067766\" articlename=\"VAOPGCPREC 50-91, Mar 29, 1991, Protection of Service Connection for a Non-existent Disability 38 U.S.C. 359 [now 1159]\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000067766/VAOPGCPREC-50-91-Mar-29-1991-Protection-of-Service-Connection-for-a-Non-existent-Disability-38-USC-359-now-1159\">VAOPGCPREC 50-1991</a></span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014455\" articlename=\"Read v. Shinseki, Jun 22, 2011, 651 F.3d 1296\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014455/Read-v-Shinseki-Jun-22-2011-651-F3d-1296\"><em>Read v. Shinseki</em></a>, 651 F.3d 1296 (2011), and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000015626\" articlename=\"Murray v. Shinseki, Jun 15, 2011, 24 Vet.App. 420\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000015626/Murray-v-Shinseki-Jun-15-2011-24-VetApp-420\"><em>Murray v. Shinseki</em></a>, 24 Vet.App. 420 (2011). </span></span></span></span></span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.1.f<a id=\"1f\" name=\"1f\">.</a>  Handling a Change in Diagnosis </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&amp;mc=true&amp;node=se38.1.4_113&amp;rgn=div8\" target=\"_blank\">38 CFR 4.13</a> directs that evidence suggesting a change in the diagnosis of an SC disability must be reviewed with a goal of reconciling the discrepancy and maintaining SC for the disability, where possible.  Reconciliation is necessary to ensure<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">accuracy of the diagnosis, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">that the proper disability has been examined and is being evaluated.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Refer to the table below for actions to take when a change in diagnosis of an SC disability is shown.</span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides the actions to take when a change in diagnosis of an SC disability is shown.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If the ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">change in diagnosis is shown on a VA examination and the examiner does not reconcile the change in diagnosis</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">return the examination report for clarification as directed at <a articleid=\"554400000180517\" articlename=\"M21-1, Part IV, Subpart i, Chapter 3, Section C - Insufficient Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180517/M21-1-Part-IV-Subpart-i-Chapter-3-Section-C-Insufficient-Examinations\">M21-1, Part IV, Subpart i, 3.C</a>.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">change in diagnosis is shown in outpatient treatment records or other medical evidence</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">request a medical opinion and examination (if warranted) to reconcile the change in diagnosis.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">medical evidence definitively shows that the diagnosis has changed and that the prior diagnosis was clearly erroneous</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">follow the procedures for severance of SC as directed at <a articleid=\"554400000177972\" articlename=\"M21-1, Part X, Subpart ii, Chapter 5, Section B - Severance of Service Connection (SC)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177972/M21-1-Part-X-Subpart-ii-Chapter-5-Section-B-Severance-of-Service-Connection-SC\">M21-1, Part X, Subpart ii, 5.B</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on special procedures for handling severance of SC for disabilities granted under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=9f0ce8e46464a943446b3eabce7d0edb&amp;node=se38.1.3_1317&amp;rgn=div8\" target=\"_blank\">38 CFR 3.317</a>, see <a articleid=\"554400000177440\" articlename=\"M21-1, Part VIII, Subpart ii, Chapter 1, Section C - Rating Presumptive Service Connection (SC) Claims for Persian Gulf Veterans\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177440/M21-1-Part-VIII-Subpart-ii-Chapter-1-Section-C-Rating-Presumptive-Service-Connection-SC-Claims-for-Persian-Gulf-Veterans\">M21-1, Part VIII, Subpart ii, 1.C.2.e and f</a>.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">medical evidence shows that the change in diagnosis represents a progression of the SC disability</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">update the diagnosis to reflect the current diagnosis as well as the historical diagnosis. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  right knee arthritis (previously diagnosed as strain)</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">medical evidence shows that the change in diagnosis represents a separate disability and reflects that the SC disability still exists</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">obtain adequate evidence to evaluate the SC disability and separate the symptoms of the SC disability from the non-service-connected (NSC) disability. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on assigning a disability evaluation when the symptoms of an SC and NSC disability cannot be separated, see <a href=\"#2c\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.2.c</a>.</span></span></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\"></div><div class=\"ng-scope\"></div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">2<a id=\"2\" name=\"2\">.</a>  <span style=\"font-family: arial, helvetica, sans-serif\">Determining a Disability Evaluation Based on Rating Schedule Criteria</span></span></span></h2><div class=\"ng-scope\"></div><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic includes general principles for determining a disability evaluation based on rating schedule criteria, including</span></span><ul><li><a href=\"#2a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">relationships within evaluation criteria</span></span></a></li><li><a href=\"#2b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">separating individual findings and pyramiding</span></span></a></li><li><a href=\"#2c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating symptoms of SC and NSC disabilities that cannot be separated</span></span></a></li><li><a href=\"#2d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">considering rating criteria that utilize “such as”</span></span></a></li><li><a href=\"#2e\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">choosing between two levels of evaluation</span></span></a></li><li><a href=\"#2f\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assignment of zero-percent evaluations</span></span></a></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2g\" target=\"_self\">assigning a 10-percent evaluation for multiple noncompensable SC disabilities</a></span></span></li><li><a href=\"#2h\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining the retroactive applicability of a new statute or regulation</span></span></a></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2i\" target=\"_self\">effect of rating schedule readjustment</a></span></span></span></span> </span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2j\" target=\"_self\">assigning staged ratings</a></span>, and</span></span></span></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><a href=\"#2k\" target=\"_self\">use of the Evaluation Builder</a>.</span></span></span></span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">September 15, 2021</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.a<a id=\"2a\" name=\"2a\">.</a>  Relationships Within Evaluation Criteria</span></span> </h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In determining which fact findings are required to make a legal conclusion, <em>generally</em> if regulatory criteria are</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>conjunctive</em></strong> (separated by “and”), all of the conjoined criteria must be met for the legal standard of entitlement to be met, or </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>disjunctive</em></strong> (separated by “or”), any one of the alternative criteria will support entitlement to the benefit. </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The manner in which evaluation criteria relate to the lower and higher evaluation criteria within the same DC is also relevant when assigning evaluations. </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Cumulative</em></strong> rating criteria are characterized by the lower evaluations building upon each other.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Successive</em></strong> rating criteria are a type of cumulative criteria characterized by higher evaluations for increased duration of symptoms.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Variable</em></strong> rating criteria are characterized by a lack of relationship between one set of evaluation criteria to the higher or lower evaluation criteria for the same DC.  In variable rating criteria, symptoms could potentially meet the criteria required for a higher evaluation without satisfying the criteria for a lesser evaluation. </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Conjunctive language is <em>always</em> subject to the reasonable doubt principles in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=451dcd74588d4aa8acd200cd3853dd5c&amp;mc=true&amp;node=se38.1.3_1102&amp;rgn=div8\" target=\"_blank\">38 CFR 3.102</a> when the evidence is in relative equipoise or when there is a question regarding degree of disability.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0ae5982f9f120fb01bba1c23b9baeef5&amp;mc=true&amp;node=se38.1.4_121&amp;rgn=div8\" target=\"_blank\">38 CFR 4.21</a> does not apply to conjunctive rating criteria. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ea513727c052ceaff09990d59f484fe1&amp;mc=true&amp;node=se38.1.4_17&amp;rgn=div8\" target=\"_blank\">38 CFR 4.7</a> is an important consideration when evaluating a disability using variable rating criteria. </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the application of </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the rating schedule, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ea513727c052ceaff09990d59f484fe1&amp;mc=true&amp;node=se38.1.4_121&amp;rgn=div8\" target=\"_blank\">38 CFR 4.21</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ea513727c052ceaff09990d59f484fe1&amp;mc=true&amp;node=se38.1.4_17&amp;rgn=div8\" target=\"_blank\">38 CFR 4.7</a> in variable rating criteria, see <a articleid=\"554400000014537\" articlename=\"Tatum v. Shinseki, Sep 28, 2009, 23 Vet.App. 152\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014537/Tatum-v-Shinseki-Sep-28-2009-23-VetApp-152\"><em>Tatum v. Shinseki</em></a>, 23 Vet.App. 152 (2009), and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">utilizing successive rating criteria, see <a articleid=\"554400000014801\" articlename=\"Camacho v. Nicholson, Jul 6, 2007, 21 Vet.App. 360\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014801/Camacho-v-Nicholson-Jul-6-2007-21-VetApp-360\"><em>Camacho v. Nicholson</em></a>, 21 Vet.App. 360 (2007).    </span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.b<a id=\"2b\" name=\"2b\">.</a>  Separating Individual Findings and Pyramiding</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Do <em>not</em> separate individual findings when these findings, in their entirety, constitute one disability.  This is</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">fundamental to the proper evaluation of a disability, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">consistent with the prohibition against pyramiding under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=4c5988bd39998d168ebeca3f1b3051b3&amp;mc=true&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  <strong><em>Pyramiding</em></strong> is rating the same physical manifestations of a disability under two separate DCs.  Separate evaluations are warranted where none of the symptomatology for any one condition duplicates or overlaps another (<a articleid=\"554400000066775\" articlename=\"Esteban v. Brown, February 25, 1994, 6 Vet.App. 259 (1994)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000066775/Esteban-v-Brown-February-25-1994-6-VetApp-259-1994\"><em>Esteban v. Brown</em></a>, 6 Vet.App. 259, 261-62 (1994)).</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 1</em></strong>:  A disability of a tibia with malunion, limitation of dorsiflexion, eversion, inversion, and traumatic arthritis of the ankle would be evaluated under one DC, <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=4c5988bd39998d168ebeca3f1b3051b3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5262</a>, in accordance with the effect upon ankle function, with no separate evaluation for the limitation of motion or traumatic arthritis.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 2</em></strong>:  A shoulder disability manifest as limitation of motion of the arm is entitled to a single rating under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=4c5988bd39998d168ebeca3f1b3051b3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5201</a>, regardless of how many planes of motion are affected.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>  </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 3</em></strong>:  Instability of the knee (<a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=4c5988bd39998d168ebeca3f1b3051b3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257</a>) may be evaluated separately from limited motion of the knee due to arthritis (<a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=4c5988bd39998d168ebeca3f1b3051b3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003</a>).</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Refe</em></strong>r<strong><em>ence</em></strong>:  For more information on separating individual findings for knee disabilities, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014410\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section B - Musculoskeletal Disabilities of the Extremities and Spine\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014410/M21-1-Part-V-Subpart-iii-Chapter-1-Section-B-Musculoskeletal-Disabilities-of-the-Extremities-and-Spine\">M21-1, Part V, Subpart iii, 1.B.4</a> </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000043704\" articlename=\"VAOPGCPREC 23-97, Jul 1, 1997, Multiple Ratings for Knee Disability\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043704/VAOPGCPREC-23-97-Jul-1-1997-Multiple-Ratings-for-Knee-Disability\">VAOPGCPREC 23-1997</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000043745\" articlename=\"VAOPGCPREC 09-98, Aug 14, 1998, Multiple Ratings for Musculoskeletal Disability and Applicability of 38 CFR §§ 4.40, 4.45, and 4.59\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043745/VAOPGCPREC-09-98-Aug-14-1998-Multiple-Ratings-for-Musculoskeletal-Disability-and-Applicability-of-38-CFR-440-445-and-459\">VAOPGCPREC 9-1998</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.c<a id=\"2c\" name=\"2c\">.</a>  Evaluating Symptoms of SC and NSC Disabilities That Cannot Be Separated</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If it is not possible to separate the effects of an NSC condition from those of an SC condition, reasonable doubt, under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&amp;mc=true&amp;node=se38.1.3_1102&amp;rgn=div8\" target=\"_blank\">38 CFR 3.102</a>, should be resolved in the Veteran’s favor with regard to whether certain signs and symptoms can be attributed to the SC condition.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When evaluating an SC disability for rating purposes, if it is not possible to differentiate the Veteran’s symptoms from an SC and NSC disability, all symptoms should be deemed related to the SC disability and rated accordingly. </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>: </span></span></span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Although the combined symptoms of the SC and NSC disabilities are used to support the assigned disability evaluation, the NSC disability is not considered SC. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The decision that the symptoms of the SC and NSC disabilities cannot be separated is a medical determination.  When the record is not clear as to whether the symptoms can be separated, obtain a medical opinion for clarification.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating symptoms of SC and NSC disabilities that </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">cannot be separated, see <a articleid=\"554400000071778\" articlename=\"Mittleider v. West, May 8, 1998, 11 Vet.App. 181 (1998)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000071778/Mittleider-v-West-May-8-1998-11-VetApp-181-1998\"><em>Mittleider v. West</em></a>, 11 Vet.App. 181 (1998), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">can be separated, see <a articleid=\"554400000141824\" articlename=\"Langdon v. Wilkie, Feb 5, 2020, No. 32 Vet.App. 291 (2020)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000141824/Langdon-v-Wilkie-Feb-5-2020-No-32-VetApp-291-2020\"><em>Langdon v. Wilkie</em></a>, 32 Vet.App. 291 (2020)</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evidence requiring further development, see <a articleid=\"554400000180487\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section B - Making Partial Rating Decisions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180487/M21-1-Part-V-Subpart-ii-Chapter-3-Section-B-Making-Partial-Rating-Decisions\">M21-1, Part V, Subpart ii, 3.B</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">returning examination reports for clarification, see <a articleid=\"554400000180517\" articlename=\"M21-1, Part IV, Subpart i, Chapter 3, Section C - Insufficient Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180517/M21-1-Part-IV-Subpart-i-Chapter-3-Section-C-Insufficient-Examinations\">M21-1, Part IV, Subpart i, 3.C</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.d<a id=\"2d\" name=\"2d\">.</a>  Considering Rating Criteria That Utilize “Such As” </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The use of the phrase “such symptoms as,” or a similar phrase, followed by a list of examples, provides guidance as to the variety of symptoms contemplated for each rating, and permits consideration of other symptoms, particular to each Veteran and condition.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on the use of the term “such symptoms as” in the schedule of ratings for mental disorders, see <a articleid=\"554400000014772\" articlename=\"Mauerhan v. Principi, Oct 30, 2002, 16 Vet.App. 436\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014772/Mauerhan-v-Principi-Oct-30-2002-16-VetApp-436\"><em>Mauerhan v. Principi</em></a>, 16 Vet.App. 436 (2002). </span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.e<a id=\"2e\" name=\"2e\">.</a>  Choosing Between Two Levels of Evaluation  </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ea513727c052ceaff09990d59f484fe1&amp;mc=true&amp;node=se38.1.4_17&amp;rgn=div8\" target=\"_blank\">38 CFR 4.7</a> provides that where there is a question upon review of the evidence as to which of two evaluations shall be assigned, the higher evaluation will be assigned if the disability picture more nearly approximates the criteria required for that rating.  Otherwise, the lower rating will be assigned.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ea513727c052ceaff09990d59f484fe1&amp;mc=true&amp;node=se38.1.4_17&amp;rgn=div8\" target=\"_blank\">38 CFR 4.7</a> does not preclude application of the reasonable doubt doctrine.  When the decision maker concludes that the facts equally (or approximately equally) support two levels of evaluation such that each is as likely as not warranted, the higher evaluation will be awarded.  </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on the application of variable, cumulative, and successive rating criteria and when <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ea513727c052ceaff09990d59f484fe1&amp;mc=true&amp;node=se38.1.4_17&amp;rgn=div8\" target=\"_blank\">38 CFR 4.7</a> applies, see <a href=\"#2a\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.2.a</a>. </span></span></span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.f<a id=\"2f\" name=\"2f\">.</a>  Assignment of Zero-Percent Evaluations</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In every instance where the schedule does not provide a zero-percent evaluation for a DC, a zero-percent evaluation shall be assigned when the requirements for a compensable evaluation are not met.</span></span></div><div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Exception</em></strong>:  Never assign a zero-percent evaluation to a condition for which the rating schedule directs a <em>prescribed, schedular minimum</em> rating.  Prescribed, schedular minimum ratings, in this context as well as that of <a articleid=\"554400000180508\" articlename=\"M21-1, Part IV, Subpart i, Chapter 2, Section F - Failure to Report and Rescheduling Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180508/M21-1-Part-IV-Subpart-i-Chapter-2-Section-F-Failure-to-Report-and-Rescheduling-Examinations\">M21-1, Part IV, Subpart i, 2.F.1.a</a> and <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=eab5b3e0424d8121bd7f6c2732e6b76d&amp;mc=true&amp;node=se38.1.3_1327&amp;rgn=div8\" target=\"_blank\">38 CFR 3.327(b)</a>, refer exclusively to instances in which the rating schedule requires assignment of a certain compensable evaluation once the underlying disability manifests or exists in the manner described.  Examples include</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=16af5fb28ba76a754f6ecef7dd67bf08&amp;mc=true&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8009</a>, which requires that residuals of brain vessel hemorrhage be assigned a minimum rating of 10 percent</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=16af5fb28ba76a754f6ecef7dd67bf08&amp;mc=true&amp;node=se38.1.4_1104&amp;rgn=div8\" target=\"_blank\">38 CFR 4.104, DC 7019</a>, which requires that residuals of cardiac transplantation be assigned a minimum rating of 30 percent, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=16af5fb28ba76a754f6ecef7dd67bf08&amp;mc=true&amp;node=se38.1.4_1116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.116, DC 7617</a>, which requires that postoperative removal of the uterus and both ovaries be assigned a minimum rating of 50 percent.</span></span></div></li></ul></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on assignment of zero-percent evaluations, see <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=61f2f61603a865de451e02bd45f7a4cc&amp;mc=true&amp;node=se38.1.4_131&amp;rgn=div8\" target=\"_blank\">38 CFR 4.31</a>.   </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.g<a id=\"2g\" name=\"2g\">.</a>  Assigning a 10-Percent Evaluation for Multiple Noncompensable SC Disabilities</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=fd9b2c21bfb81e420813d1e23f907878&amp;mc=true&amp;node=se38.1.3_1324&amp;rgn=div8\" target=\"_blank\">38 CFR 3.324</a>, a single 10-percent evaluation may be assigned when all of the following criteria are met:<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a Veteran is suffering from two or more separate permanent noncompensable SC disabilities</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">there are no other compensable SC disabilities, <strong><em>and</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the SC disabilities clearly interfere with normal employability. </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Payment of compensation at the 10-percent rate cannot be made in combination with any other compensable disability evaluation.   </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When entitlement to a 10-percent rating has been established but a subsequent rating decision establishes entitlement to a compensable evaluation for an SC disability, the grant of the compensable SC evaluation is considered the greater benefit.  It is unnecessary to close out the past grant of entitlement under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=fd9b2c21bfb81e420813d1e23f907878&amp;mc=true&amp;node=se38.1.3_1324&amp;rgn=div8\" target=\"_blank\">38 CFR 3.324</a>, as VBMS recognizes payment for the compensable disability as the greater benefit.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on when to put into issue in a rating decision and decide entitlement to a 10-percent evaluation under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=fd9b2c21bfb81e420813d1e23f907878&amp;mc=true&amp;node=se38.1.3_1324&amp;rgn=div8\" target=\"_blank\">38 CFR 3.324</a>, see <a articleid=\"554400000180486\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section A - Determining the Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180486/M21-1-Part-V-Subpart-ii-Chapter-3-Section-A-Determining-the-Issues\">M21-1, Part V, Subpart ii, 3.A.2.b</a>.</span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.h<a id=\"2h\" name=\"2h\">.</a>  Determining the Retroactive Applicability of a New Statute or Regulation </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The provisions of a statutory or regulatory change to rating schedule criteria for evaluating disabilities are generally not retroactive unless retroactive applicability is specifically directed.  When a change that revises the rating schedule’s evaluation criteria does not specify the intent for retroactive application, assume that the new criteria do not apply prior to the effective date of the corresponding regulatory change.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  For claims pending on the date that a rating schedule provision is changed, it is usually appropriate to apply the</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>old</em> regulation in assigning disability evaluations for periods that precede the date of the change, and</span></span></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>new</em> regulation in evaluating a disability for any period that begins on or after the date of the change.  After the effective date of the regulation change</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a higher evaluation must be based on the new regulation, but</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the new regulatory criteria cannot be applied to reduce an evaluation unless actual improvement has occurred as discussed in <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=43e62a604ef05ea7b4f46398ac3f3652&amp;mc=true&amp;node=se38.1.3_1951&amp;rgn=div8\" target=\"_blank\">38 CFR 3.951(a)</a> and <a href=\"#2i\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.2.i</a>.</span></span></div></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> <strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">protection of a disability rating based on adjustment to the rating schedule, see <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=43e62a604ef05ea7b4f46398ac3f3652&amp;mc=true&amp;node=se38.1.3_1951&amp;rgn=div8\" target=\"_blank\">38 CFR 3.951(a)</a></span></span></div></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the retroactive applicability of a new statute or regulation, see <a articleid=\"554400000043875\" articlename=\"VAOPGCPREC 07-03, Nov 19, 2003, Application of Veterans Claims Assistance Act of 2000 to Claims Pending on Date of Enactment\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043875/VAOPGCPREC-07-03-Nov-19-2003-Application-of-Veterans-Claims-Assistance-Act-of-2000-to-Claims-Pending-on-Date-of-Enactment\">VAOPGCPREC 7-2003</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">effective dates that are based on a change of law or regulation, see <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A.6</a>, and</span></span></li></ul></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning staged ratings, see <a href=\"#2j\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.2.j</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.i<a id=\"2i\" name=\"2i\">.</a>  Effect of Rating Schedule Readjustment</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When the rating schedule is readjusted, in no event shall the readjustment cause a Veteran’s disability evaluation in effect on the effective date of the readjustment to be reduced unless an improvement in the disability is shown to have occurred, even if the combined evaluation is not reduced, as indicated in <a articleid=\"554400000043413\" articlename=\"VAOPGCPREC 19-92, Sep 29, 1992, Protection of Disability Ratings Under Pub. L. No. 102-86, § 103 Stat. 414-415 (1991)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043413/VAOPGCPREC-19-92-Sep-29-1992-Protection-of-Disability-Ratings-Under-Pub-L-No-102-86-103-Stat-414-415-1991\">VAOPGCPREC 19-1992</a> and <a href=\"https://www.law.cornell.edu/uscode/text/38/1155\" target=\"_blank\">38 U.S.C. 1155</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This precedent opinion also provides that when a Veteran is receiving the minimum evaluation for a condition at the time the rating schedule is revised, and the condition subsequently undergoes an exacerbation resulting in a higher evaluation, if the condition returns to the same, symptom-free status it was in at the time of the rating schedule change, a noncompensable evaluation under the new criteria will be assigned.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  The February 3, 1988, revision of criteria for rating psychiatric disorders is considered a liberalizing law/VA issue as indicated in </span></span><a articleid=\"554400000071782\" articlename=\"Sabol v. Derwinski, Mar 3, 1992, 2 Vet.App. 228 (1992)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000071782/Sabol-v-Derwinski-Mar-3-1992-2-VetApp-228-1992\"><em>Sabol v. Derwinski</em></a>, U.S. Vet.App. No. 90-1123 (1992), <a href=\"https://www.law.cornell.edu/uscode/text/38/5110\" target=\"_blank\">38 U.S.C. 5110(g)</a>, <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=146f7c1f9831a1627289cc33bb649ebe&amp;mc=true&amp;node=se38.1.3_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 3.114</a>, and <a articleid=\"554400000043413\" articlename=\"VAOPGCPREC 19-92, Sep 29, 1992, Protection of Disability Ratings Under Pub. L. No. 102-86, § 103 Stat. 414-415 (1991)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043413/VAOPGCPREC-19-92-Sep-29-1992-Protection-of-Disability-Ratings-Under-Pub-L-No-102-86-103-Stat-414-415-1991\">VAOPGCPREC 19-1992</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on protection and rating schedule changes, see <a articleid=\"554400000177962\" articlename=\"M21-1, Part X, Subpart ii, Chapter 1, Section B - Protected Ratings\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177962/M21-1-Part-X-Subpart-ii-Chapter-1-Section-B-Protected-Ratings\">M21-1, Part X, Subpart ii, 1.B.4</a>.</span></span></span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.j<a id=\"2j\" name=\"2j\">.</a>  Assigning Staged Ratings</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The term <strong><em>staged rating </em></strong>refers to the assignment of separate ratings for separate periods of time based on the facts found.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=e4773620348b09dbbd647c08574adce5&amp;node=se38.1.3_1105&amp;rgn=div8\" target=\"_blank\">38 CFR 3.105(e)</a> does not apply to a staged rating.  Additionally, <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=e4773620348b09dbbd647c08574adce5&amp;node=se38.1.3_1105&amp;rgn=div8\" target=\"_blank\">38 CFR 3.105(e)</a> is inapplicable to disabilities rated under DCs containing a note that “any change in evaluation . . . shall be subject to the provisions of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=e4773620348b09dbbd647c08574adce5&amp;node=se38.1.3_1105&amp;rgn=div8\" target=\"_blank\">38 CFR 3.105(e)</a>” if the reduction is part of a staged rating assigned in the grant of an original claim for such disability.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on assigning staged ratings, see</span></span></div><ul><li><div><a articleid=\"554400000073346\" articlename=\"Fenderson v. West, Jan 20, 1999, 12 Vet.App. 119 (1999)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000073346/Fenderson-v-West-Jan-20-1999-12-VetApp-119-1999\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Fenderson v. West</em></span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, 12 Vet.App. 119 (1999)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000015428\" articlename=\"Hart v. Mansfield, Nov 19, 2007, 21 Vet.App. 505\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000015428/Hart-v-Mansfield-Nov-19-2007-21-VetApp-505\"><em>Hart v. Mansfield</em></a>, 21 Vet.App. 505 (2007)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014490\" articlename=\"Tatum v. Shinseki, Nov 3, 2010, 24 Vet.App. 139\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014490/Tatum-v-Shinseki-Nov-3-2010-24-VetApp-139\"><em>Tatum v. Shinseki</em></a>, 24 Vet.App. 139 (2010), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000177969\" articlename=\"M21-1, Part X, Subpart ii, Chapter 4, Section A - Rating Decisions for Reduction Due to Improvement\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177969/M21-1-Part-X-Subpart-ii-Chapter-4-Section-A-Rating-Decisions-for-Reduction-Due-to-Improvement\">M21-1, Part X, Subpart ii, 4.A.1.e</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.2.k<a id=\"2k\" name=\"2k\">.</a>  Use of the Evaluation Builder</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Use of the Evaluation Builder in assigning disability evaluations in claims for compensation is mandatory.  The Evaluation Builder is programmed to represent accurate policy and procedure and should not be overridden unless specific authorization exists for doing so.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When a change in policy or procedure is officially issued in either regulatory, policy, or procedural guidance and causes the Evaluation Builder to generate inaccurate results for a temporary period of time until updates can be made, decision makers are required to override the Evaluation Builder or use appropriate workarounds so that disabilities are accurately evaluated in accordance with published guidance.  In these situations, decision makers will be directed to utilize overrides or workarounds. </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><h2 class=\"ng-scope\"><br/> </h2><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">3<a id=\"3\" name=\"3\">.</a>  Extra-Schedular Consideration</span></span></h2><p class=\"ng-scope\"><br/> </p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains information about extra-schedular consideration, including</span></span></div><ul><li><div><a href=\"#3a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">extra-schedular evaluations in compensation claims</span></span></a></div></li><li><div><a href=\"#3b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">approving extra-schedular evaluation in compensation claims</span></span></a></div></li><li><div><a href=\"#3c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">when to submit compensation claims for extra-schedular consideration</span></span></a></div></li><li><div><a href=\"#3d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">extra-schedular evaluations under 38 CFR 3.321(b)(1)</span></span></a></div></li><li><div><a href=\"#3e\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">procedure for referring claims for extra-schedular consideration</span></span></a></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#3f\" target=\"_self\">extra-schedular consideration in pension claims</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">exhibit of </span></span><ul><li><a href=\"#3g\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">38 CFR 3.321(b)(1) referral memorandum</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">, and</span></span></li><li><a href=\"#3h\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">38 CFR 4.16(b) referral memorandum</span></span></span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">.</span></span></span></span></li></ul></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">September 15, 2021</span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.3.a<a id=\"3a\" name=\"3a\">.</a>  Extra-Schedular Evaluations in Compensation Claims</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Consider the issue of entitlement to an extra-schedular evaluation in compensation claims under</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> only where</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the issue is expressly raised by the Veteran, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">there is evidence of exceptional or unusual circumstances indicating that the rating schedule may be inadequate to compensate for the average impairment of earning capacity due to disability (for example, marked interference with employment or frequent periods of hospitalization), and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.4_116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.16(b)</a> whenever</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the issue is expressly stated</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">there is evidence that the Veteran may be unable to secure or follow a substantially gainful occupation because of an SC disability, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">total disability based on individual unemployability (IU) cannot be awarded on a schedular basis.</span></span></div></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If the Veteran explicitly raises the issue of extra-schedular entitlement, but the general criteria for referring the claim to Compensation Service are not met, the decision and decision notice must include an explanation of that determination.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In the interest of maximizing available benefit entitlement in all cases, regional offices (ROs) must explore and exhaust all possible schedular rating methods and alternatives, to include the following, before referring a claim to Compensation Service for extra-schedular consideration:</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">analogous ratings</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assignment of the higher of two potentially applicable evaluations under <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=b509a87eff218a6c722212f02dc527b2&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_17\" target=\"_blank\">38 CFR 4.7</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">resolution of reasonable doubt in favor of the claimant under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b509a87eff218a6c722212f02dc527b2&amp;mc=true&amp;node=se38.1.4_13&amp;rgn=div8\" target=\"_blank\">38 CFR 4.3</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">permissible means of evaluating SC disabilities under multiple separate DC criteria without pyramiding, and/or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">awards of</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">IU benefits, and/or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">special monthly compensation (SMC).</span></span></li></ul></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">total disability claims, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000043649\" articlename=\"VAOPGCPREC 06-96, Aug 16, 1996, Issues Related to Floyd v. Brown, 9 Vet. App. 88 (1996)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043649/VAOPGCPREC-06-96-Aug-16-1996-Issues-Related-to-Floyd-v-Brown-9-Vet-App-88-1996\">VAOGCPREC 6-1996</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000067475\" articlename=\"Floyd v. Brown, Apr 17, 1996, 9 Vet.App. 88 (1996)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000067475/Floyd-v-Brown-Apr-17-1996-9-VetApp-88-1996\"><em>Floyd v. Brown</em></a>, 9 Vet.App. 88 (1996), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000075991\" articlename=\"Bagwell v. Brown, Jul 3, 1996, 9 Vet.App. 337\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000075991/Bagwell-v-Brown-Jul-3-1996-9-VetApp-337\"><em>Bagwell v. Brown</em></a>, 9 Vet.App. 337 (1996)</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">extra-schedular evaluations under</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a>, see <a href=\"#3d\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.3.d</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.4_116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.16(b)</a>, see <a href=\"#4b\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.4.b</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the threshold analysis involved in determining propriety of extra-schedular rating referrals, see <a articleid=\"554400000114050\" articlename=\"Morgan v. Wilkie, May 16, 2019, 31 Vet.App. 162 (2019)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000114050/Morgan-v-Wilkie-May-16-2019-31-VetApp-162-2019\"><em>Morgan v. Wilkie</em></a>, 31 Vet.App. 162 (2019).</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.3.b<a id=\"3b\" name=\"3b\">.</a>  Approving Extra-Schedular Evaluations in Compensation Claims</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Only the Director of the Compensation Service (214D) may approve extra-schedular evaluations in compensation claims submitted under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> and <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.4_116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.16(b)</a>.</span></span></p></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.3.c<a id=\"3c\" name=\"3c\">.</a>  When to Submit Compensation Claims for Extra-Schedular Consideration</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Submit compensation claims to Compensation Service for extra-schedular consideration under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cd14d08678c9b47bace132cd4528664a&amp;node=se38.1.4_116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.16(b)</a> if a(n)</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">unusual or exceptional disability picture, with such related factors as marked interference with employment or frequent periods of hospitalization, renders the schedular evaluation inadequate for </span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">an individual disability, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">total rating cannot be assigned solely because</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the minimum schedular requirements of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cd14d08678c9b47bace132cd4528664a&amp;node=se38.1.4_116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.16</a> are not met, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">a total rating is considered warranted.</span></span></div></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  ROs are only required to refer claims for extra-schedular consideration when that issue, whether or not argued by the claimant, is reasonably substantiated by the evidence of record.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on<span>﻿</span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the procedure for referring claims to Compensation Service for extra-schedular consideration, see </span><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3d\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.3.d</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">extra-schedular consideration, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><a articleid=\"554400000165853\" articlename=\"Long v. Wilkie, Dec 30, 2020, No. 16-1537\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000165853/Long-v-Wilkie-Dec-30-2020-No-16-1537\">Long v. Wilkie,</a></em> 33 Vet.App. 167 (2020)</span></span></div></li><li><div><a articleid=\"554400000083886\" articlename=\"King v. Shulkin, Dec 21, 2017, 29 Vet.App. 174 (2017)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000083886/King-v-Shulkin-Dec-21-2017-29-VetApp-174-2017\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>King v. Shulkin</em></span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, 29 Vet.App. 174 (2017) </span></span></div></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000056914\" articlename=\"Yancy v. McDonald, Feb 26, 2016, 27 Vet.App. 484 (2016)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000056914/Yancy-v-McDonald-Feb-26-2016-27-VetApp-484-2016\"><em>Yancy v. McDonald</em></a>, 27 Vet.App. 484 (2016)</span></span></span></span></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014690\" articlename=\"Thun v. Peake, Apr 23, 2008, 22 Vet.App. 111\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014690/Thun-v-Peake-Apr-23-2008-22-VetApp-111\"><em>Thun v. Peake</em></a>, 22 Vet.App. 111 (2008), and</span></span></span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000015164\" articlename=\"Anderson v. Shinseki, Mar 13, 2009, 22 Vet.App. 423\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000015164/Anderson-v-Shinseki-Mar-13-2009-22-VetApp-423\"><em>Anderson v. Shinseki</em></a>, 22 Vet.App. 423 (2009).</span></span></span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.3.d<a id=\"3d\" name=\"3d\">.</a> Extra-Schedular Evaluations Under 38 CFR 3.321(b)(1) </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=fd9b2c21bfb81e420813d1e23f907878&amp;mc=true&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> provides for referral for extra-schedular consideration based on the impact of a single disability.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Refer a claim to the Compensation Service for a determination on whether an extra-schedular rating may be assigned when <em>both</em> of the following criteria are met:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the established schedular criteria are inadequate to describe the severity and symptoms of the claimant’s disability, <em>and</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">there are other indications of an exceptional or unusual disability picture, such as marked interference with employment or frequent periods of hospitalization.</span></span></span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>:  </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Do not routinely refer a claimant’s request for extra-schedular consideration to Compensation Service.  When a claimant requests extra-schedular consideration for an SC disability, only refer the claim if the referral criteria specified above are met.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Do not dismiss the potential for extra-schedular referral based solely on the availability of a higher schedular disability evaluation.  The availability of a higher schedular rating is irrelevant in determining whether a request for extra-schedular evaluation is warranted unless the disability is evaluated as 100-percent disabling.  A disability may be considered for extra-schedular evaluation when less than the maximum available schedular evaluation is assigned as long as all other criteria for referral, as discussed above, have been met.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When the schedular rating criteria contemplates the symptoms necessitating the use of assistive devices as well as the severity of those symptoms, referral for extra-schedular consideration under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=fd9b2c21bfb81e420813d1e23f907878&amp;mc=true&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> is not warranted based solely on the use of assistive devices.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">when to address the issue of entitlement to an extra-schedular evaluation under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=fd9b2c21bfb81e420813d1e23f907878&amp;mc=true&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> in a rating decision, see </span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000043649\" articlename=\"VAOPGCPREC 06-96, Aug 16, 1996, Issues Related to Floyd v. Brown, 9 Vet. App. 88 (1996)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043649/VAOPGCPREC-06-96-Aug-16-1996-Issues-Related-to-Floyd-v-Brown-9-Vet-App-88-1996\">VAOPGCPREC 6-1996</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the relevance of the use of assistive devices in extra-schedular consideration, see <a articleid=\"554400000094873\" articlename=\"Spellers v. Wilkie, Sep 7, 2018, 30 Vet.App. 211 (2018)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000094873/Spellers-v-Wilkie-Sep-7-2018-30-VetApp-211-2018\"><em>Spellers v. Wilkie</em></a>, 30 Vet.App. 211 (2008).</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.3.e<a id=\"3e\" name=\"3e\">.</a>  Procedure for Referring Claims for Extra-Schedular Consideration</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Follow the steps in the table below when referring claims for extra-schedular consideration under either <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cd14d08678c9b47bace132cd4528664a&amp;node=se38.1.4_116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.16(b)</a>. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a step-action table.  Column 1 is the step number and column 2 provides the steps when referring claims for extra-schedular consideration under either 38 CFR 3.321(b)(1) or 38 CFR 4.16(b).  Step 4 contains an additional table.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 72px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Step</strong></span></span></div></th><th scope=\"col\" style=\"width: 438px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Action</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 72px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1</span></span></div></td><td style=\"width: 438px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Complete the appropriate memorandum as shown in <a href=\"#3g\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.3.g</a> or <a href=\"#3h\" target=\"_self\">h</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  When referring a claim to Compensation Service for consideration of <em>both</em> <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cd14d08678c9b47bace132cd4528664a&amp;node=se38.1.4_116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.16(b)</a>, the request may be submitted under the same memo as long as the memo fully discusses both extra-schedular provisions and provides recommendations for both.</span></span></div></td></tr><tr><td style=\"width: 72px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">2</span></span></div></td><td style=\"width: 438px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Obtain the required signatures on <a href=\"http://vbaw.vba.va.gov/bl/20/cio/20s5/forms/VBA-21-0961-ARE.pdf\" target=\"_blank\"><em>VA Form 21-0961, Rating Decision/Administrative Decision/Formal Finding/Statement of the Case (SOC)/Supplemental Statement of the Case (SSOC) (Electronic Signatures)</em></a>.</span></span></div></td></tr><tr><td style=\"width: 72px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">3</span></span></div></td><td style=\"width: 438px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Upload the memorandum and all other relevant documents to the Veteran’s electronic claims folder.</span></span></div></td></tr><tr><td style=\"width: 72px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">4</span></span></div></td><td style=\"width: 438px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Use the table below to refer the claim to Compensation Service for extra-schedular consideration.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides the actions to take to refer the claim to Compensation Service for extra-schedular consideration.\"><thead><tr><th scope=\"col\" style=\"width: 154px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If the claim is …</strong></span></span></div></th><th scope=\"col\" style=\"width: 268px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then …</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 154px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">processed in the National Work Queue (NWQ) environment</span></span></div></td><td style=\"width: 268px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign the <em>Compensation Service Review – Extraschedular</em> special issue indicator to the relevant contention(s), and <em>Compensation Service Case Review</em> tracked item in accordance with the <em><a href=\"https://dvagov.sharepoint.com/sites/VACOOFOGeneral/SitePages/Home.aspx\" target=\"_blank\">NWQ Phase 1 &amp;2 Playbook</a></em> to ensure proper routing to Compensation Service.</span></span></div></td></tr><tr><td style=\"width: 154px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">not processed in the NWQ environment</span></span></div></td><td style=\"width: 268px; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign the</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Compensation Service Review – Extraschedular</em> special issue indicator to the relevant contention(s), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Compensation Service Case Review</em> tracked item, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">manually broker the end product (EP) to <em>Compensation Service (Washington DC)</em>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on manually brokering EPs, see the <em>VBMS Core User Guide</em>.</span></span></div></td></tr></tbody></table><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr></tbody></table></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on </span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning special issue indicators and tracked items, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000046277\" articlename=\"M21-1, Part III, Subpart i, Chapter 2, Section F - Record Maintenance During the Development Process\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000046277/M21-1-Part-III-Subpart-i-Chapter-2-Section-F-Record-Maintenance-During-the-Development-Process\">M21-1, Part III, Subpart i, 2.F</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the <em>VBMS Core User Guide</em></span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.3.f<a id=\"3f\" name=\"3f\">.</a>  Extra-Schedular Consideration in Pension Claims</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In pension claims, consider the issue of entitlement to an extra-schedular evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=57486552d6dc8005efd62f58097584c3&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(2)</a> whenever a Veteran fails to meet the schedular requirements for permanent and total (P&amp;T) disability.  If approval is recommended, forward the rating decision and claims folder to the Veterans Service Center Manager, Pension Management Center Manager, or designee for signature.</span></span></p></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 86pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-size: 14px\">V.ii.3.D.3.g<a id=\"3g\" name=\"3g\">.</a>  Exhibit 1:  38 CFR 3.321(b)(1) Referral Memorandum</span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This exhibit contains a sample of the memorandum completed for <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&amp;node=se38.1.3_1321&amp;rgn=div8\" target=\"_blank\">38 CFR 3.321(b)(1)</a> referrals. </span></span></div><div> <span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 516px; padding: 0px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>DEPARTMENT OF VETERANS AFFAIRS</strong></span></span></div><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>[RO Name</strong></span></span></div><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong> RO Address]</strong></span></span></div><div align=\"center\" style=\"margin-left: 58.5pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>[Date]</strong></span></span></div><div style=\"margin-left: 58.5pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Director                                                           In Rely Refer To:</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Compensation Service (214D)                         <strong>[RO #]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Department of Veterans Affairs                        <strong>[File Number]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Central Office                                                   <strong>[Veteran’s Name]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">810 Vermont Ave. NW</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Washington, DC 20420</span></span></div><div style=\"margin-left: 58.5pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>SUBJECT:  </strong><em>Administrative Review for Entitlement to Increased Evaluation in Accordance with 38 CFR § 3.321(b)(1)</em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>BACKGROUND INFORMATION:  [List service information, such as branch, dates, and place(s) of service.]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>STATEMENT OF ISSUE:  [State specific review requested, including any relevant time period and whether the issue is part of a Board of Veterans’ Appeals (BVA) remand.]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  <em>Review for entitlement to an increased evaluation on an extra-schedular basis for bilateral hearing loss</em>.   </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>EVIDENCE:  [List the evidence used for this review.]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Rating decision dated August 1, 2008</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>BVA decision/remand dated November 1, 2015</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>VA examinations dated June 7, 2008, July 10, 2010, September 12, 2015, and June 20, 2016 </em></span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>DISCUSSION:  [Discuss medical evidence in detail for each SC disability related to the request for all pertinent time periods, to include medical evidence found within the file and the BVA remand.]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong><em>:  </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Service connection has been established for bilateral hearing loss.  This condition has been evaluated at zero percent disabling since January 6, 2008.  The Veteran is requesting an increased evaluation for this condition. BVA remanded this issue on November 1, 2015, and directed that the case be referred for consideration of entitlement to an increased evaluation on an extra-schedular basis from January 6, 2008, to present.  </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>VA examinations dated June 7, 2008, July 10, 2010, and September 12, 2015, document that the Veteran’s hearing loss has been appropriately evaluated at zero percent disabling for the time period of this review.  Speech recognition scores were 96% for the right ear and 94% for the left ear.     </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>On June 20, 2016, another examination was performed.  Testing revealed a slight deterioration in the bilateral hearing loss; however this change is not sufficient to warrant an increased evaluation on a schedular basis.  Speech recognition scores remained at previous levels.  The examiner stated that the Veteran’s hearing loss would not preclude employment.  The examiner further stated that the Veteran would have some difficulty working in situations with a lot of background noise.</em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Evidence shows that the Veteran attended college for two years and worked as an engineer following separation from service.  He retired from this position in January of 2012, after 23 years.  Evidence does not show that the bilateral hearing loss interfered with employment.  </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Extra-schedular evaluations are assigned in cases where an exceptional or unusual disability picture is presented with such related factors as marked interference with employment or frequent periods of hospitalization that renders application of regular rating schedular standards impractical. No unusual or exceptional disability pattern has been demonstrated that would render application of the regular rating criteria as impractical.  The evidentiary record does not demonstrate that the symptomatology consistently associated with the service-connected bilateral hearing loss supports an increased evaluation on a schedular or extra-schedular basis for any time period.</em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>RECOMMENDATION:</strong>  <strong>[Provide a recommendation, to include an effective date, if applicable.]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  <em>Deny an increased evaluation on an extra-schedular basis for bilateral hearing loss.</em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>SIGNATURES</strong>:<strong>  [Document signatures on <em>VA Form 21-0961</em> by following procedures in M21-1, Part X, Subpart v, 1.C.3.e.]</strong></span></span></div></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.3.h<a id=\"3h\" name=\"3h\">.</a>  Exhibit 2:  38 CFR 4.16(b) Referral Memorandum</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This exhibit contains a sample of the memorandum completed for <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cd14d08678c9b47bace132cd4528664a&amp;node=se38.1.4_116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.16(b)</a> referrals. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 524px; padding: 0px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>DEPARTMENT OF VETERANS AFFAIRS</strong></span></span></div><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>[RO Name</strong></span></span></div><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>RO Address]</strong></span></span></div><div align=\"center\" style=\"margin-left: 58.5pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">[<strong>Date</strong>]</span></span></div><div style=\"margin-left: 58.5pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Director                                                           In Rely Refer To:</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Compensation Service (214D)                          [<strong>RO #</strong>]</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Department of Veterans Affairs                        [<strong>File Number</strong>]</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Central Office                                                   [<strong>Veteran’s Name</strong>]</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">810 Vermont Ave. NW</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Washington, DC 20420</span></span></div><div style=\"margin-left: 58.5pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>SUBJECT:  </strong><em>Administrative Review for Entitlement to Total Disability Rating Based on Individual Unemployability (TDIU) in Accordance with 38 CFR 4.16(b)</em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>BACKGROUND INFORMATION:  [List service information, such as branch, dates, and place(s) of service.] </strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>STATEMENT OF ISSUE:  [State specific review requested, including any relevant time period and whether the issue is part of a BVA remand.]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  <em>Review for entitlement to TDIU benefits on an extra-schedular basis for the period June 20, 2016, to May 1, 2017</em>.  </span></span></div><div style=\"margin-left: 7.9pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>EVIDENCE:  [List the evidence used for this review]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Rating decision dated April 15, 2016</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>BVA remand dated June 1, 2017</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>VA Form 21-8940, Veteran's Application for Increased Compensation Based on Unemployability, received January 12, 2016</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Transcript of hearing, dated May 19, 2017</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>VA examinations dated December 2012, March 2014, and May 2016</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Social Security Administration (SSA) disability transmittal sheet, dated January 30, 2016 </em></span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>DISCUSSION:  [Discuss medical evidence in detail for each SC disability related to the request for all pertinent time periods, to include medical evidence found within the file and the BVA remand.]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Service connection has been established for three conditions.  Posttraumatic stress disorder (PTSD) was evaluated at 30 percent disabling effective January 2, 2013, and increased to 50 percent disabling effective January 3, 2016; arthritis of the right knee has been evaluated at 10 percent disabling since June 5, 2010, and bilateral hearing loss has been evaluated at zero percent disabling since June 5, 2010.  The combined evaluation for compensation was 10 percent effective June 5, 2010; 40 percent effective January 2, 2013, and 60 percent effective January 3, 2016.  BVA remanded this issue on January 1, 2017, and directed that the case be referred for entitlement to IU benefits on an extra-schedular basis from January 2, 2013, to present date.  </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Evidence from SSA shows that the Veteran was found to be entitled to SSA disability benefits in June of 2013.  The primary condition utilized to make that decision was disorders of the spine, and the secondary condition was disorders of the knee.  </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Evidence shows that the Veteran attended college for four years and worked as an automobile salesperson following separation from service.  He retired from this position in January of 2012, after 26 years.  Evidence does not show that the service-connected conditions interfered with employment.  </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>VA psychiatric examinations performed in December of 2012, March of 2014, and May of 2016, demonstrate that the Veteran’s PTSD has deteriorated since 2013.  The Veteran has never been hospitalized for PTSD, and records show no therapy sessions prior to January of 2016.  The Veteran took prescription medication prescribed by his family doctor until December of 2015, when he first started treatment with a psychiatrist.  Evidence shows no hallucinations, delusions, or suicidal or homicidal ideations at any time.  The Veteran’s depression and anxiety (symptoms of PTSD) increased in severity in late 2015.  He started having occasional panic attacks and having difficulty getting along with family members and friends.  He started to isolate himself more often and had difficulty sleeping most nights.  Evidence does not include any medical opinions indicating that the PTSD interfered with prior employment or would prevent employment at any time. </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>A VA musculoskeletal examination performed in March of 2014, revealed full motion of the right knee with pain.  X-ray evidence revealed arthritis.  No instability of the knee was found.  The Veteran reported pain with extended periods of walking and standing.  He takes over-the-counter pain medication as needed for knee pain.  He does not use a cane or other ambulatory aids.  No surgery has been performed on the right knee.   </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>A VA examination performed in March of 2014 revealed a mild bilateral hearing loss.  The Veteran was able to hear well during the examination.  His speech discrimination scores were 98% in each ear.  The examiner stated that the hearing loss would not affect employment.  </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>It is the established policy of the Department of Veterans Affairs that all Veterans who are unable to secure and follow a substantially gainful occupation by reason of service-connected disabilities shall be rated totally disabled. None of the available evidence supports the Veteran’s contention that any of his service-connected disabilities or a combination of the effects of the disabilities prevents all types of gainful activity.  </em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>RECOMMENDATION:</strong>  <strong>[Provide a recommendation, to include an effective date, if applicable.]</strong></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  <em>Grant entitlement to TDIU on an extra-schedular basis effective June 20, 2017.</em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>SIGNATURES</strong>:<strong>  [Document signatures on <em>VA Form 21-0961</em> by following procedures in M21-1, Part X, Subpart v, 1.C.3.e.]</strong></span></span></div></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><br/> </div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">4<a id=\"4\" name=\"4\">.</a>  P&amp;/T Evaluations</span></span></h2><p class=\"ng-scope\"> <br/> </p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>Introduction</span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td id=\"cke_tmp_268\" style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information on the rating determination for DEA under 38 U.S.C. Chapter 35, including</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">definition of a </span></span><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4a\" target=\"_self\">total disability</a>, and </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4b\" target=\"_self\">permanent disability</a> </span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4c\" target=\"_self\">requirement for permanence</a> </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4d\" target=\"_self\">evidentiary threshold for establishing permanence</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4e\" target=\"_self\">establishing permanence for chronic, progressive disabilities</a> </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">date of P&amp;T disability </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4f\" target=\"_self\">when claimed or raised as a subordinate issue</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4g\" target=\"_self\">upon cancellation or dismissal of review examination control</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4h\" target=\"_self\">P&amp;T reasons for decision</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4i\" target=\"_self\">addressing the P&amp;T status of disabilities normally requiring a review examination</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#4j\" target=\"_self\">granting P&amp;T without Dependents' Educational Assistant (DEA)</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>Change Date</span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>July 21, 2022</span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td id=\"cke_tmp_257\" style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.ii.3.D.4.a<a id=\"4a\" name=\"4a\">.</a>  Definition:  Total Disability</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span><strong><em>Total disability</em></strong> means</span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>schedular or extraschedular evaluations of 100 percent under, or by analogy to, any DC in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=4ec4eb3c48e6693b6bf7e49e9ebde32f&amp;tpl=/ecfrbrowse/Title38/38cfr4_main_02.tpl\" target=\"_blank\">38 CFR Part 4</a> </span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>a combined evaluation of 100 percent, or</span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>a total evaluation on the basis of IU.</span></span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span><strong><em>Reference</em></strong>:  For more information on a total disability evaluation for the loss of paired organs or extremities under <a href=\"https://www.law.cornell.edu/uscode/text/38/1160\" target=\"_blank\">38 U.S.C. 1160</a>, see </span></span></span><a articleid=\"554400000070028\" articlename=\"Kimberlin v. Brown, May 26, 1993 , 5 Vet.App. 174 (1993)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000070028/Kimberlin-v-Brown-May-26-1993-5-VetApp-174-1993\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em>Kimberlin v. Brown</em></span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">, 5 Vet.App. 174 (1993).</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td id=\"cke_tmp_261\" style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.ii.3.D.4.b<a id=\"4b\" name=\"4b\">.</a>  Definition: Permanent Disability</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Permanent disability</em></strong> means disabling manifestations reasonably certain to continue throughout the lifetime of the individual. </span></span></div><div></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on permanent disability, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.law.cornell.edu/uscode/text/38/3501\" target=\"_blank\">38 U.S.C. 3501</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=459514a12a64ee1b890429fad032291f&amp;mc=true&amp;node=se38.1.3_1340&amp;rgn=div8\" target=\"_blank\">38 CFR 3.340</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=c6f2286438cc61a9d4395fa2998d5f5e&amp;mc=true&amp;node=se38.1.4_115&amp;rgn=div8\" target=\"_blank\">38 CFR 4.15</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td id=\"cke_tmp_262\" style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.ii.3.D.4.c<a id=\"4c\" name=\"4c\">.</a>  Requirement for Permanence</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>The mere existence of a total disability evaluation is not sufficient to establish a P&amp;T evaluation. The evidence must establish permanence of the total evaluation, as discussed in <a href=\"#4d\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.4.d</a>. Total evaluations assigned under the following provisions are temporary:</span></span></span></p><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>prestabilization (<a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c2c16dc73e959659a6eef24c36105820&amp;mc=true&amp;node=se38.1.4_128&amp;rgn=div8\" target=\"_blank\">38 CFR 4.28</a>)</span></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>extended VA hospitalization (<a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=a941a0a731f28ad99f9e88ff05886639&amp;mc=true&amp;node=se38.1.4_129&amp;rgn=div8\" target=\"_blank\">38 CFR 4.29</a>)</span></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>convalescence (<a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=a941a0a731f28ad99f9e88ff05886639&amp;mc=true&amp;node=se38.1.4_130&amp;rgn=div8\" target=\"_blank\">38 CFR 4.30</a>), and </span></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>any DC that provides for a limited period of total disability for convalescence such as joint replacements or cardiac procedures.</span></span></span></li></ul><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span><strong><em>Exceptions</em></strong>: </span></span></span></p><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>Veterans who are considered P&amp;T disabled prior to the assignment of a 100-percent evaluation under a DC with a limited duration and future examination will be considered permanently disabled during the total evaluation.  The status of permanency is reconsidered following completion of the examination.  <strong><em>Example</em></strong>:  A Veteran who is considered permanently and totally disabled because of a heart disorder based on metabolic equivalents (METs) undergoes cardiac transplantation surgery.  The Veteran would continue to be considered P&amp;T disabled for the duration of the one-year convalescent period under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=c2c16dc73e959659a6eef24c36105820&amp;mc=true&amp;node=se38.1.4_1104&amp;rgn=div8\" target=\"_blank\">38 CFR 4.104, DC 7019</a>. </span></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span>A temporary total evaluation on the date of death will establish a P&amp;T disability.  Total disability did persist from the date assigned until the end of the person’s life.  </span></span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td id=\"cke_tmp_263\" style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.ii.3.D.4.d<a id=\"4d\" name=\"4d\">.</a>  Evidentiary Threshold for Establishing Permanence</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td id=\"cke_tmp_271\" style=\"width: 516px; padding: 0px;\"><div><div class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Permanence of a total disability evaluation may be established when the evidence of record clearly establishes that a disability is expected to continue at its current level of severity.  However, clear and specific evidence is not required to establish permanence. </span></span></div><div class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">When the evidence of record does not clearly or specifically show that the total disability will continue but <b><i>also</i></b> <b><i>does not show</i></b> that a reexamination to ascertain improvement is warranted pursuant to <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=433083b6a1e6e00f64b71b3d179f2442&amp;node=se38.1.3_1327&amp;rgn=div8\" target=\"_blank\">38 CFR 3.327(b)(2)</a>, concede permanence of the evaluation based on a reasonable certainty that improvement is not likely.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The following fact patterns demonstrate scenarios in which P&amp;T disability is established based on the preponderance of the evidence of record.</span></span></div></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Evidence at the time of evaluation affirmatively shows that the total disability will continue for the remainder of the person’s life.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Evidence at the time of evaluation does not specifically support that the total disability will continue for the remainder of the person’s life but does not show that the condition is likely to improve pursuant to <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=03dcc6a5661cd6041b66b7187846900a&amp;mc=true&amp;node=se38.1.3_1327&amp;rgn=div8\" target=\"_blank\">38 CFR 3.327(b)(2)</a>.  In such cases, a future examination control is inappropriate so the total disability rating is static; in the absence of re-evaluation, total disability is likely to continue for the remainder of the person’s life.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">At or before the time of maturation of a future examination diary pertinent to the continuation of total disability, the future examination control is canceled because</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">the future exam control was erroneous under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=03dcc6a5661cd6041b66b7187846900a&amp;mc=true&amp;node=se38.1.3_1327&amp;rgn=div8\" target=\"_blank\">38 CFR 3.327(b)(2)</a>, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">evidence is received that changes the prior assessment that the condition was likely to improve.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Total disability has been in effect for 20 or more years per <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=4399710342b7c46732bdabb37ef7e142&amp;mc=true&amp;node=se38.1.3_1951&amp;rgn=div8\" target=\"_blank\">38 CFR 3.951</a>.  In such cases, the total disability is protected and is therefore static and will continue for the remainder of the person’s life. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">A qualifying individual with total disability dies. In such cases, the total disability is permanent because it persisted until the end of the person’s life.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong><em>Notes</em></strong>:  </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The evidentiary threshold provided in <a href=\"https://www.law.cornell.edu/uscode/text/38/3501\" target=\"_blank\">38 U.S.C. 3501(a)(8)</a> to establish permanence is that there must be a <i>reasonable certainty</i> that the level of impairment will continue throughout the life of the disabled person.  This threshold means that there is more than an approximate balance of evidence indicating that the level of impairment will continue indefinitely.  </span></span></div></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">For historical purposes, a 100-percent evaluation under the 1925 rating schedule also meets the criteria of a “total disability, permanent in nature,” for DEA, per <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=433083b6a1e6e00f64b71b3d179f2442&amp;node=se38.1.3_1952&amp;rgn=div8\" target=\"_blank\">38 CFR 3.952</a>.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Reference</i></b>:  For more information on the definition of static disability, see <a articleid=\"554400000014553\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 2, Section B - Failure to Report for Review Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014553/M21-1-Part-IV-Subpart-ii-Chapter-2-Section-B-Failure-to-Report-for-Review-Examinations\">M21-1, Part IV, Subpart ii, 2.B.2.b</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.4.e<a id=\"4e\" name=\"4e\">.</a>  Establishing Permanence for Chronic, Progressive Disabilities</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When evidence indicates that cancer or other similarly chronic and progressive disabilities are not expected to improve, concede permanence for the disability evaluation.  Examples of indicators suggesting the likelihood that the disability status is permanent include but are not limited to</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a prescription for palliative treatment only for a cancer diagnosis</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a prescription for hospice care, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">an indicator in medical evidence that the condition is considered terminal. </span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td id=\"cke_tmp_266\" style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.ii.3.D.4.f<a id=\"4f\" name=\"4f\">.</a>  Date of P&amp;T Disability When Claimed or Raised as a Subordinate Issue</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Basic eligibility based on a P&amp;T SC disability is only established when all criteria (i.e., SC, total disability, and permanence of disability) are met.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Therefore,  the date of P&amp;T disability is the <strong><em>later of </em></strong></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the date of claim, <strong><em>or</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the date that the final criterion is factually established.  </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>:  </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If medical evidence reviewed in connection with a claim portrays an increase in SC disability, warranting a finding of permanence, establish the P&amp;T evaluation and apply the effective date provisions of whichever of the following is more applicable/appropriate:</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=28f7dc456a02310276f9dc318b73d844&amp;mc=true&amp;node=se38.1.3_1400&amp;rgn=div8\" target=\"_blank\">38 CFR 3.400(o)(2)</a>, or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=6d496b6bb62ff8f42c9407ad433b6dfd&amp;mc=true&amp;node=se38.1.3_12500&amp;rgn=div8\" target=\"_blank\">38 CFR 3.2500(h)</a>.</span></span></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When results of a VA-initiated review/future examination portray permanence of an individual or combined total disability evaluation, establish basic eligibility to a P&amp;T evaluation as of the date the examination was performed.</span></span></div></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Attribute examination or other findings dated after the date of claim back to the date of claim unless there is specific evidence there was a change to total disability or to permanece of disability between the date of claim and the date of the evidence.  </span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><strong>Example</strong></em>:  A VA examination finding that contains an opinion on permanence of disability would be attributed to the date of claim unless there was specific evidence dated on or after the date of claim, and prior to the VA examination date, indicating that the total disability was likely to improve, in which case the date of permanence would be the date of examination. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">effective dates, see <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">entitlement to Dependents' Educational Assistance (DEA) arising from P&amp;T evaluations, see <a articleid=\"554400000173634\" articlename=\"M21-1, Part XIII, Subpart i, Chapter 1, Section A - Ratings for Dependents' Educational Assistance (DEA)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000173634/M21-1-Part-XIII-Subpart-i-Chapter-1-Section-A-Ratings-for-Dependents-Educational-Assistance-DEA\">M21-1, Part XIII, Subpart i, 1.A</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td id=\"cke_tmp_267\" style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.ii.3.D.4.g<a id=\"4g\" name=\"4g\">.</a>  Date of P&amp;T Disability Upon Cancellation or Dismissal of Review Examination Control</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Use the table below to determine the date of P&amp;T disability when</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">there is total disability but no indication of permanence based on an established future or review examination control, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a P&amp;T determination is subsequently necessitated by one of the following actions:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">cancellation of the future examination control prior to maturation, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determination that a review examination should not be scheduled at the time the future examination control matures. </span></span></div></li></ul></li></ul><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"height: 0px; width: 504px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an When-Then table.  Column 1 provides the criteria and column 2 provides the actions to take to determine the date of P&amp;T disability.\" width=\"504\"><thead><tr><th scope=\"col\" style=\"width: 50%; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>When the action is based on ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 50%; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 50%; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a determination that the examination control was initially set up in <em>error</em></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  In violation of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=4399710342b7c46732bdabb37ef7e142&amp;mc=true&amp;node=se38.1.3_1327&amp;rgn=div8\" target=\"_blank\">38 CFR 3.327(b)(2)</a>, a future examination control is set for a condition, like amytrophic lateral sclerosis (ALS), that can only be rated at 100 percent and is, by its nature, permanent.</span></span></div></td><td style=\"width: 50%; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">set the date of P&amp;T disability <strong><em>as if the future examination control were never established</em></strong>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Explanation</em></strong>:  The examination control was erroneous; therefore, the condition was static at the time of the rating decision establishing SC.</span></span></div></td></tr><tr><td style=\"width: 50%; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a difference in judgment rather than a specific error in the initial future examination control</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  The rating activity determines, prior to scheduling, that a review examination should not be scheduled as planned because the conclusion of likely future improvement used to set the future examination control was not well justified by the facts.</span></span></div></td><td style=\"width: 50%; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">use the <strong><em>date of review</em></strong><strong><em> </em></strong>for the date of P&amp;T disability.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Explanation</em></strong>:  This is essentially a new determination of permanency on the date of review caused by reexamination of the facts.</span></span></div></td></tr><tr><td style=\"width: 50%; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">new evidence that changes the prior assessment that the total disability is likely to improve, as indicated by a future examination control</span></span></div></td><td style=\"width: 50%; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">use the <strong><em>date that the new evidence is received </em></strong>for the date of P&amp;T disability. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Exception</em></strong>:  When the new evidence portraying disability permanence is dated within one year prior to the date of the current review, apply the effective date provisions of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=03dcc6a5661cd6041b66b7187846900a&amp;mc=true&amp;node=se38.1.3_1400&amp;rgn=div8\" target=\"_blank\">38 CFR 3.400(o)(2)</a>.</span></span></div><div><p><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on effective dates</span></span></p><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">for increased compensation, see <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A.5</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">based on historical <a href=\"https://www.govinfo.gov/content/pkg/CFR-2014-title38-vol1/pdf/CFR-2014-title38-vol1-sec3-157.pdf\" target=\"_blank\">38 CFR 3.157</a>, see <a articleid=\"554400000180493\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section B - Historical Guidance on the Assignment of Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180493/M21-1-Part-V-Subpart-ii-Chapter-4-Section-B-Historical-Guidance-on-the-Assignment-of-Effective-Dates\">M21-1, Part V, Subpart ii, 4.B.1</a>.</span></span></li></ul></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.4.h<a id=\"4h\" name=\"4h\">.</a>  P&amp;T Reasons for Decision</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Rating decisions establishing P&amp;T status must provide </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">the basis for the decision, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">a discussion of the evidence supporting the decision.</span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.4.i<a id=\"4i\" name=\"4i\">.</a>  Addressing the P&amp;T Status of Malignancies</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">VBMS-R’s system-generated language for evaluating totally disabling SC malignancies or other disabilities normally requiring a review examination usually includes reference to the scheduling of a mandatory review examination intended to determine recurrence or residual disability.</span></span></span></span></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When, however, P&amp;T status of the SC disability has been conceded in light of the guidance in <a href=\"#4e\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.4.e</a>, edit the rating decision narrative by replacing the system-generated text displayed in the left column of the table below with the text displayed in the right column.</span></span></div></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a two-column table.  The first colum shows the text that VBMS-R generates.  The second column shows the text claims processors must use to replace the system-generated text.\" width=\"638\"><thead><tr><th scope=\"col\" style=\"width: 318px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>VBMS-R System-Generated Text</strong></span></span></div></th><th scope=\"col\" style=\"width: 192px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Replacement Text</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 318px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure.  Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination.  Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of 38 CFR §3.105(e).  If there has been no local recurrence or metastasis, you will be rated on residuals.</em></span></span></div></td><td style=\"width: 192px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>The medical evidence shows that permanence of this disability has been established.  Consequently, no future VA examination will be requested.</em></span></span></div></td></tr></tbody></table></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning P&amp;T evaluations for amyloid light chains amyloidosis, see <a articleid=\"554400000180513\" articlename=\"M21-1, Part V, Subpart iii, Chapter 9 - Hematologic and Lymphatic Systems\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180513/M21-1-Part-V-Subpart-iii-Chapter-9-Hematologic-and-Lymphatic-Systems\">M21-1, Part V, Subpart iii, 9.2.a</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">historical assignment of P&amp;T evaluations for multiple myeloma and chronic lymphocytic leukemia, see <a articleid=\"554400000180513\" articlename=\"M21-1, Part V, Subpart iii, Chapter 9 - Hematologic and Lymphatic Systems\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180513/M21-1-Part-V-Subpart-iii-Chapter-9-Hematologic-and-Lymphatic-Systems\">M21-1, Part V, Subpart iii, 9.2.f</a>.</span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.4.j<a id=\"4j\" name=\"4j\">.</a>  Granting P&amp;T without DEA</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When a P&amp;T evaluation is established, if eligibility for DEA is not being established as an ancillary benefit in the same rating decision (for example, when eligibility for DEA has been granted in a prior decision or is not warranted for a grant of benefits under <a href=\"http://www.law.cornell.edu/uscode/text/38/1151\" target=\"_blank\">38 U.S.C. 1151</a>), modify the rating narrative text to provide a discussion of only the permanence determination unless a decision is specifically required for DEA.</span></span></div><ul></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\"> <br/> </div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">5<a id=\"5\" name=\"5\">.</a>  <span style=\"font-family: arial, helvetica, sans-serif\">Principles of Disability Evaluation for Specific Conditions</span></span></span></h2><div class=\"ng-scope\"> <br/> </div><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information about evaluating specific conditions or circumstances, including</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#5a\" target=\"_self\">evaluating malignant neoplasms and associated impairments</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#5b\" target=\"_self\">examples of evaluating diagnosed disabilities due to malignant neoplasms</a></span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#5c\" target=\"_self\">evaluating an SC disability eliminated by NSC amputation</a>, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#5d\" target=\"_self\">considering recurrent or refractory symptoms</a>.</span></span></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">September 15, 2021</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.5.a<a id=\"5a\" name=\"5a\">.</a>  Evaluating Malignant Neoplasms and Associated Impairments </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Use the table below to determine whether a symptom or condition associated with an active malignant neoplasm may be separately evaluated during the period in which a 100-percent evaluation is warranted for the active malignant neoplasm.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides information to determine whether a symptom or condition associated with an active malignant neoplasm may be separately evaluated during the period in which a 100-percent evaluation is warranted for the active malignant neoplasm.  \" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If the condition is a ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">purely symptomatic complaint arising from the malignant neoplasm</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">do not assign a separate evaluation.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">symptom arising from treatment for the malignant neoplasm</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">do not assign a separate evaluation.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">diagnosed disability deemed to be caused by or related to the malignant neoplasm</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">apply <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=50a41ee00084c63bbd36743e2d91ac9b&amp;mc=true&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a> to determine whether the symptoms of the diagnosed disability are considered in the 100-percent evaluation for the malignant neoplasm</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">review the evaluation criteria for both conditions and other applicable provisions to determine whether separate evaluations are allowable, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">if the pyramiding rule in <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=50a41ee00084c63bbd36743e2d91ac9b&amp;mc=true&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a> has not been violated and separate evaluations are otherwise allowable, assign a separate evaluation.</span></span></div></li></ul><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  When the DC for the active malignancy is directive as to how to evaluate residuals of the cancer, conditions or symptoms that</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">would be rated as residuals should not be assigned a separate evaluation during the pendency of the 100-percent evaluation for the active malignancy, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">would not be rated as residuals may be granted separately and concurrently with the 100-percent evaluation. </span></span></div></li></ul></div></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">metastatic malignant neoplasm affecting a different body system than is affected by the primary SC neoplasm</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign a separate evaluation.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  For the purpose of determining entitlement to SMC at the statutory housebound rate under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=40434d9c86faab57a7d9d9c857264a90&amp;mc=true&amp;node=se38.1.3_1350&amp;rgn=div8\" target=\"_blank\">38 CFR 3.350(i)(1)</a>, carcinoma that has metastasized and involves two different body systems would generally be considered separate and distinct.  The fact that there is an etiological relationship does not preclude considering the impact and effects as separate and distinct.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">metastatic malignant neoplasm affecting the same body system as is affected by the primary SC neoplasm</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">do not assign a separate evaluation.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  This guidance is applicable when language within a particular DC refers to <em>malignant neoplasms </em>in plural.</span></span></div></td></tr></tbody></table><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  If doubt arises as to the medical cause or association of any symptoms or diagnosis, a medical opinion should be requested for clarification. </span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></span></span></div></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assignment of separate evaluations for individual findings, see <a href=\"#2b\" target=\"_self\">M21-1, Part V, Subpart ii, 3.D.2.b</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">entitlement to SMC based on housebound status, see <a articleid=\"554400000177480\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 4, Section A - Special Monthly Compensation (SMC)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177480/M21-1-Part-VIII-Subpart-iv-Chapter-4-Section-A-Special-Monthly-Compensation-SMC\">M21-1, Part VIII, Subpart iv, 4.A.10</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.5.b<a id=\"5b\" name=\"5b\">.</a>  Examples of Evaluating Diagnosed Disabilities Due to Malignant Neoplasms </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 1</em></strong>:  SC for anxiety disorder claimed and diagnosed as secondary to active lung cancer may be granted and separately evaluated.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 2</em></strong>:  A Veteran is SC with a 100-percent evaluation assigned for active renal cancer and undergoes a nephrectomy as a part of the treatment for the renal cancer.  <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=d7c96f0fcb5a100e480ddefb72def70e&amp;mc=true&amp;node=se38.1.4_1115b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115b, DC 7528</a> directs that renal cancer is evaluated as active malignancy and its residuals are evaluated based on either voiding dysfunction or renal dysfunction.  Since a nephrectomy is evaluated either with the minimum compensable evaluation or as renal dysfunction under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=d7c96f0fcb5a100e480ddefb72def70e&amp;mc=true&amp;node=se38.1.4_1115b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115b, DC 7500</a>, the rating schedule recognizes that renal dysfunction is within the predominant symptomatology of both disabilities.  Since both criteria contemplate renal dysfunction, the nephrectomy cannot be separately evaluated.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 3</em></strong>:  A Veteran is SC with a 100-percent evaluation assigned for active renal cancer.  The Veteran is diagnosed with recurrent pyelonephritis which is characterized by symptoms of recurrent urinary tract infection.  The pyelonephritis is identified as a complication of the renal cancer.  <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=d7c96f0fcb5a100e480ddefb72def70e&amp;mc=true&amp;node=se38.1.4_1115b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115b, DC 7528</a> directs that renal cancer is evaluated as active malignancy and its residuals are evaluated based on either voiding dysfunction or renal dysfunction.  Since the pyelonephritis is characterized by recurrent urinary tract infection, which is not considered within the criteria for evaluating malignant neoplasms of the genitourinary system, a separate evaluation may be assigned under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=d7c96f0fcb5a100e480ddefb72def70e&amp;mc=true&amp;node=se38.1.4_1115b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115b, DC 7504</a> utilizing the urinary tract infection symptoms.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 4</em></strong>:  A Veteran is SC with a 100-percent evaluation assigned under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=8159d64bf6673c83b4ec1ae8a3968ad8&amp;mc=true&amp;node=se38.1.4_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.114, DC 7343</a> for active colon cancer.  The Veteran sustained a nerve injury during surgery for the colon cancer resulting in impairment of anal sphincter control with incontinence.  Since the symptoms of impairment of sphincter control with incontinence are due to a separately diagnosed disability (the nerve injury), pyramiding rules are not violated, and <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=8159d64bf6673c83b4ec1ae8a3968ad8&amp;mc=true&amp;node=se38.1.4_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.114</a> does not prohibit separate evaluations for these coexisting digestive system disabilities, a separate evaluation may be assigned for the nerve injury with impairment of sphincter control under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=8159d64bf6673c83b4ec1ae8a3968ad8&amp;mc=true&amp;node=se38.1.4_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.114, DC 7332</a>. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 5</em></strong>:  A Veteran is SC with a 100-percent evaluation assigned under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=014750e9ddd7a65ce87a8b97e5fbea6f&amp;mc=true&amp;node=se38.1.4_1115b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115b, DC 7528</a>.  A VA examination revealed a diagnosis of erectile dysfunction due to the prostate cancer.  Since <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=014750e9ddd7a65ce87a8b97e5fbea6f&amp;mc=true&amp;node=se38.1.4_1115b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115b, DC 7528</a> directs that prostate cancer is evaluated based on residuals consisting of voiding dysfunction or urinary tract infection, SC for the erectile dysfunction should be established concurrently with the 100-percent evaluation.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.5.c<a id=\"5c\" name=\"5c\">.</a>  Evaluating an SC Disability Eliminated by NSC Amputation</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Where an NSC cause necessitates amputation of an extremity resulting in elimination of an SC disability distal to the site of the amputation, do not sever SC for or reduce the evaluation of the SC disability. </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.ii.3.D.5.d<a id=\"5d\" name=\"5d\">.</a>  Considering Recurrent or Refractory Symptoms</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Many evaluation criteria require consideration of the frequency of occurrence of symptoms.  Two descriptions used throughout the rating schedule for frequency of occurrence are <em>refractory</em> and <em>recurrent</em>.</span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Recurrent</em> describes signs, symptoms, or a disease that returns after a period of remission (or a period of time during which the symptoms could not be detected).</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Refractory</em> describes a disease, condition, or symptoms that do not respond or are resistant to treatment.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example</em></strong>:  The evaluation criteria for human immunodeficiency virus (HIV)-related illness at <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=d7c96f0fcb5a100e480ddefb72def70e&amp;mc=true&amp;node=se38.1.4_188b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.88b, DC 6351</a> utilizes recurrent symptoms for the 30-percent evaluation and refractory symptoms for the 60-percent evaluation.</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000180488\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section C - Reviewing Diagnoses\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180488/M21-1-Part-V-Subpart-ii-Chapter-3-Section-C-Reviewing-Diagnoses\">&lt;-- Previous Section</a>  <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\" style=\"text-align: left\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://vbaw.vba.va.gov/bl/20/cio/20s5/forms/VBA-21-0961-ARE.pdf",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=0a84b89a963326c38da056b1f6b17b0a&mc=true&r=SECTION&n=se38.1.4_171a",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=0ae5982f9f120fb01bba1c23b9baeef5&mc=true&node=se38.1.4_121&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=146f7c1f9831a1627289cc33bb649ebe&mc=true&node=se38.1.3_1114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=1a2181df37babc2b76f6ff912573b2e2&mc=true&node=se38.1.4_12&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=433083b6a1e6e00f64b71b3d179f2442&node=se38.1.3_1327&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=433083b6a1e6e00f64b71b3d179f2442&node=se38.1.3_1952&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=4399710342b7c46732bdabb37ef7e142&mc=true&node=se38.1.3_1327&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=4399710342b7c46732bdabb37ef7e142&mc=true&node=se38.1.3_1951&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=451dcd74588d4aa8acd200cd3853dd5c&mc=true&node=se38.1.3_1102&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=4c5988bd39998d168ebeca3f1b3051b3&mc=true&node=se38.1.4_114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=4c5988bd39998d168ebeca3f1b3051b3&mc=true&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=4ec4eb3c48e6693b6bf7e49e9ebde32f&tpl=/ecfrbrowse/Title38/38cfr4_main_02.tpl",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=57486552d6dc8005efd62f58097584c3&node=se38.1.3_1321&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=73dbd1ea57aace04181d2e02e631f64b&mc=true&node=se38.1.4_173&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c2c16dc73e959659a6eef24c36105820&mc=true&node=se38.1.4_1104&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=c2c16dc73e959659a6eef24c36105820&mc=true&node=se38.1.4_128&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=cd14d08678c9b47bace132cd4528664a&node=se38.1.4_116&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&node=se38.1.3_1321&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=d1b5656bcb8a27da76e853963aa704f1&node=se38.1.4_116&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=ea513727c052ceaff09990d59f484fe1&mc=true&node=se38.1.4_121&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=ea513727c052ceaff09990d59f484fe1&mc=true&node=se38.1.4_17&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=eb7493eb29df5c572d488350d31b4925&node=pt38.1.4&rgn=div5",
    "http://www.law.cornell.edu/uscode/text/38/1151",
    "https://dvagov.sharepoint.com/sites/VACOOFOGeneral/SitePages/Home.aspx",
    "https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=b509a87eff218a6c722212f02dc527b2&mc=true&r=SECTION&n=se38.1.4_17",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=014750e9ddd7a65ce87a8b97e5fbea6f&mc=true&node=se38.1.4_1115b&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=03dcc6a5661cd6041b66b7187846900a&mc=true&node=se38.1.3_1327&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=03dcc6a5661cd6041b66b7187846900a&mc=true&node=se38.1.3_1400&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=16af5fb28ba76a754f6ecef7dd67bf08&mc=true&node=se38.1.4_1104&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=16af5fb28ba76a754f6ecef7dd67bf08&mc=true&node=se38.1.4_1116&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=16af5fb28ba76a754f6ecef7dd67bf08&mc=true&node=se38.1.4_1124a&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=28f7dc456a02310276f9dc318b73d844&mc=true&node=se38.1.3_1400&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=40434d9c86faab57a7d9d9c857264a90&mc=true&node=se38.1.3_1350&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=43e62a604ef05ea7b4f46398ac3f3652&mc=true&node=se38.1.3_1951&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=459514a12a64ee1b890429fad032291f&mc=true&node=se38.1.3_1340&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=50a41ee00084c63bbd36743e2d91ac9b&mc=true&node=se38.1.4_114&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=61f2f61603a865de451e02bd45f7a4cc&mc=true&node=se38.1.4_131&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=6d496b6bb62ff8f42c9407ad433b6dfd&mc=true&node=se38.1.3_12500&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=8159d64bf6673c83b4ec1ae8a3968ad8&mc=true&node=se38.1.4_1114&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=9f0ce8e46464a943446b3eabce7d0edb&node=se38.1.3_1317&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=a941a0a731f28ad99f9e88ff05886639&mc=true&node=se38.1.4_129&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=a941a0a731f28ad99f9e88ff05886639&mc=true&node=se38.1.4_130&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=b509a87eff218a6c722212f02dc527b2&mc=true&node=se38.1.4_13&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=c6f2286438cc61a9d4395fa2998d5f5e&mc=true&node=se38.1.4_115&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=d7c96f0fcb5a100e480ddefb72def70e&mc=true&node=se38.1.4_1115b&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=d7c96f0fcb5a100e480ddefb72def70e&mc=true&node=se38.1.4_188b&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&mc=true&node=se38.1.3_1102&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&mc=true&node=se38.1.3_1951&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&mc=true&node=se38.1.3_1957&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&mc=true&node=se38.1.4_113&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&mc=true&node=se38.1.4_114&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=de25e791c274df7cc11bb86f13119344&mc=true&node=se38.1.4_127&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=e4773620348b09dbbd647c08574adce5&node=se38.1.3_1105&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=eab5b3e0424d8121bd7f6c2732e6b76d&mc=true&node=se38.1.3_1327&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=fd9b2c21bfb81e420813d1e23f907878&mc=true&node=se38.1.3_1321&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=fd9b2c21bfb81e420813d1e23f907878&mc=true&node=se38.1.3_1324&rgn=div8",
    "https://www.ecfr.gov/current/title-38/section-4.20",
    "https://www.govinfo.gov/content/pkg/CFR-2014-title38-vol1/pdf/CFR-2014-title38-vol1-sec3-157.pdf",
    "https://www.law.cornell.edu/uscode/text/38/1155",
    "https://www.law.cornell.edu/uscode/text/38/1160",
    "https://www.law.cornell.edu/uscode/text/38/3501",
    "https://www.law.cornell.edu/uscode/text/38/5110"
  ],
  "scraped_at": "2025-06-16T22:42:38.373209",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates"
}